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Theranostic is a new paradigm in nanomedicine, aiming to design 
unique nanostructures where diagnostic and therapeutic tools are 
combined. The development of new nanotechnologies has allowed 
fast and important step forwards in this direction, frequently focused 
on the optimization of materials for cancer treatment. The aim of my 
research work has been not only the design and preparation of 
nanomaterials for theranostic applications, focusing the 
investigation on dye doped Pluronic Silica nanoparticles (PluSNPs, 
a biocompatible silica core surrounded by a polymeric PEG shell), 
but also the development of methods or technical tools, both based 
on fluorescence, for an improved characterization of such materials. 
These complementary themes are presented in different chapters, 
each describing in detail the strategy, the experimental work and the 
conclusions yielded by the data treatment and interpretation.   
A first significant part of my research has been devoted to the 
improvement of the principal synthetic strategies to obtain 
luminescent Pluronic/silica nanoparticles able to act as efficient 
luminescent biomarkers (chapter 2) or theranostic agents integrating 
drug loading and release in the same structure (chapter 4).The 
synthesis of PluSNPs for drug delivery purposes was carefully tuned 
to obtain a good entrapment and discharge of lipophilic 
chemotherapy drugs (Sorafenib) from the nanoparticles with a 
suitable kinetic for application. This drug delivery system showed 
very promising effects in vitro as tumor angiogenic controller.   
A punctual characterization of such materials is not trivial due to their 
high complexity confined in a space in the nanometric range. To this 
goal I have investigated a new fluorescence based solvatochromic 
method, that we propose to map the polarity of neighboring 
nanoenviroments (Chapter 3). This method evidenced the complex 
architecture of the Pluronic shell of this nanoparticles which can 
promote both hydrophilic and hydrophobic interactions shining light 
on the host/guest abilities of these structures.  
Aiming to in vivo applications the understanding of the possible 
nanoparticle interactions with the bioenvironment is of fundamental 
importance. To this goal I have both studied: i) the interaction 
between PluSNPs and a fluorescent labeled hyaluronic acid (one of 
 
 
the chief hydrophilic components of the extracellular matrix) and ii) 
a novel fluorescence cross-correlation based imaging method (2D-
pCF) to map dynamical processes in cellular environments. In the 
first case fluorescence-based investigation has been used to follow 
the formation of hyaluronic acid/PluSNPs interactions (chapter 5) to 
propose a model mechanism for the description of 
nanoparticle/biomolecular corona formation. It is important to 
underline that the nanoparticles interacting with the hyaluronic acid 
have proven to be internalized faster, a possible indication of their 
increased theranostic abilities. 
As important as the formation of these complex aggregates is the 
study of their motion and localization in the cells. To this goal I have 
spent a period abroad at the Laboratory of Fluorescence Dynamics, 
University of California, Irvine, where the group of Professor Enrico 
Gratton has developed a novel fluorescence cross-correlation based 
imaging method (2D-pCF), 2D-pCF is useful to achieve the map of 
dynamical processes and the trajectories of fluorescent 
nanostructures in cellular environments. I applied this technique to 
the investigation of motion of a fluorescent protein involved on the 
repair mechanism upon a DNA damage (chapter 6) but, in principle, 
can be extended to the investigation of cellular internalization 
phenomena which involves fluorescent molecular and/or 
nanostructured materials. 
To summarize, in this thesis I have presented new powerful 
fluorescence-based techniques for the design, synthesis and 
characterization – also in cellular environments – of nanostructures 
based on Pluronic Silica Nanoparticles. In this way, more efficient 
theranostic nanoparticles have been obtained, with the expectation 
that the techniques described here can be extended also to other 
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FRET  Forster Resonance Energy Transfer 
2D-pCF Two-Dimensional pair Correlation Function 
Alt-EJ Alternative End-Joining 
APTES Amino Propyl Triethoxy Silane 
ATM Ataxia–telangiectasia mutated  
ATMi Ataxia–telangiectasia mutated inhibitor 
ATR Ataxia–telangiectasia and Rad3 related 
ATRi Ataxia–telangiectasia and Rad3 related inhibitor 
BSA Bovine Serum Albumin 
CA Contrast Agent 
CETS  Carboxyethylsilanetriol 
CMC Critical micellar Concentration 
CT Computed Tomography 
Cy5  Cyanine 5 
DDR DNA Damage Response 
DEAC Diethylamino Coumarin 
DLS Dynamic Light Scattering 
DMAP 4-Dimethylaminopyridine 
DNA  Deoxyribonucleic Acid 
DNA-PKA DNA-dependent protein kinase  
DNA-PKAi DNA-dependent protein kinase inhibitor 
DSB Double Strands Breaks 
EGFP Enhanced Green Fluorescent Protein 
EPR Enhanced Permeability and Retention 
ERK extracellular signal–regulated kinases 
Et2O Diethyl Ether 
F-127 Pluronic F-127 
F-127 Amine Pluronic F-127 Amine derivative 
F-127 CARBO Pluronic F-127 Carboxy derivative 
FCS Fluorescence Correlation Spectroscopy 
FDA Food and Drug Administration 
H-bonds Hydrogen Bond 
HR Homologous Recombination 
 
 
Hya Hyaluronic Acid 
MRI Magnetic Resonance Imaging 
mRNA messenger Ribonucleic Acid 
NHEJ Non-Homologous End-Joining 
NIR  Near Infra-Red 
NP Nanoparticle 
NR Nile Red 
OI Optical Imaging 
P  Prodan 
PARP Poly (ADP-ribose) polymerase 
PARPi Poly (ADP-ribose) polymerase inhibitor 
PB Phosphate Buffer 
PBS Phosphate Buffer Saline 
PEG Polyethylene Glycol 
PET Positron Emission Tomography 
PluSNP Pluronic F-127 Silica Nanoparticle 
PPO Polypropylene Oxide 
QDs Quantum Dots 
QY Quantum Yield 
RALN Right Axillary Lymph Node 
RB Rhodamine B  
SLN  Sentinel lymph Node 
SPECT Single-photon emission computed tomography 
SRF Sorafenib Tosylate 
SSA Single Strand Annealing 
TEM Transmission Electron Microscope 
TEOS  Tetra Ethyl Orthosilicate 
TMOS  Tetra Methyl Ortho Silicate 
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1.1 Diagnosis, Therapy, Theranostic 
Nanotechnology is an emerging and fast-growing discipline that has 
extraordinary applications in health and environmental fields. In 
medicine, nanotechnology is expected to improve life expectancy, 
as well as in the last century the improvement of diagnostic and 
therapeutic procedures has promoted better condition and 
increased life quality. Nanomaterials are considered one of the most 
important and promising frontiers of research due to the possibility 
to design nanoplatforms combining more features in a single object 
yielding materials with extraordinarily versatile and customized 
properties. For example, the combination of therapeutic and 
diagnostic tools in a single object - referred as theranostic - is a very 
intriguing multimodal strategy in nanomedicine which could 
overcome unsolved problems. Theranostic nanomedicine is 
emerging as a promising therapeutic paradigm. It takes advantage 
of the high capacity of nanoplatforms to ferry cargos and loads 
together with imaging functions. The resulting nano-systems, 
capable of diagnosis, drug delivery and monitoring the therapeutic 
response, are expected to play a significant role in the dawning era 
of personalized medicine in particular in cancer treatment.1–4 In the 
last decades, numerous drugs for cancer treatment have been 
discovered5, nevertheless, they generally present severe limitations 
compromising the therapy efficiency. Chemotherapy drugs, 
commonly, provoke hazardous side effects due to their intrinsic 
cytotoxicity. moreover, tumor cells can develop drug resistance. The 
main limit of the traditional medicine toward cancer treatment is a 
not satisfactory selectivity of the drug for these tissues, in fact, 
traditional drugs are spread out in the whole body with no specific 
distribution, showing a systemic toxicity. Side effects as hair loss, 
diarrhea, anemia and muscular pain can frequently appear during 
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chemotherapy becoming additional very relevant issues for the 
patients in the fight against cancer6. Moreover, tumor cells can 
develop drug resistance, eliminating any beneficial effect the 
therapy 
 A possible solution to increase the therapy efficacy and to limit side 
effects can be found thanks to nanotechnology, since nanosystems 
can be designed to be accumulated selectively inside the tumor 
tissue. Solid tumors, in fact, have different characteristics with 
respect to healthy tissue. An important difference is angiogenesis 
which consists of an increase of the vascularization level and the 
extensive production of muscular mediators, both yielding an 
abnormal vascular architecture and the alteration of lymphatics 
system. All this can be conveniently exploited in nanomaterials 
presenting intrinsic features enabling them to work as nanocarriers 
to selectively deliver tailored quantity of drugs in specific tissues. On 
the other hand, the same goal can be also reached by designing 
customized objects with ad hoc functions to target only the desired 
tissues. The spontaneous entrapment and accumulation of nano-
sized species in the tumor is due to a phenomenon called Enhanced 
Permeability and Retention (EPR)7 caused by its abnormal vascular 
architecture (see infra). In particular, the EPR effect permits the 
accumulation of macromolecules, and in general of nanoscaled 
objects, in the interstitial of tumor tissues with concentration higher 
than the blood plasma 8,9. 
As mentioned above, the versatility of nanostructured carriers can 
allow to integrate in the same nanoparticle also diagnostic features. 
These materials, in fact, have also been widely studied in the last 
decades as diagnostic agents for in vitro and in vivo applications. 
Indeed, biocompatible nanomaterials are considered as great 
candidates for the preparation of a new generation of contrast 
agents (CAs) since they allow to increase the signal output in many 
diagnostic techniques. Nanoparticle-based contrast agents present 
all the characteristics to become efficient tools for medical 
diagnostics and imaging in many modalities with possible valuable 
3 
 
repercussions on many medical areas including surgery. 
Nanostructures can be designed to allow also multimodal imaging, 
which could result much more efficient than the single analysis 
possible with conventional molecular-scale CAs. Moreover, they 
provide new abilities for in vivo detection and enhanced targeting 
efficiencies through longer circulation times, designed clearance 
pathways, and multiple binding capacities. Properly protected, they 
can be safely used for the fabrication of various functional systems 
with targeting properties, reduced toxicity, and proper excretion from 
the body. Nanosized CAs are expected to become standard practice 
in the field of imaging in a close future, for both bioimaging and 
medical imaging. In this contest, one of the technique which today 
can offer the widest plethora of applications ranging from the study 
of biological processes at molecular level to the surgery practice is 
optical imaging (OI)10. Luminescent nanomaterials for optical 
techniques are, as a matter of the fact, the frontier for the 
development of emerging technologies with great potential for the 
improvement of disease prevention, diagnosis, and treatment. 
For all these reasons, fluorescence, nanomaterials, drug delivery, 
theranostic are focus topics with a key role within this thesis.  
 
1.2 Theranostic Nanoparticles 
The term “theranostic” has been coined to define ongoing efforts to 
combine diagnostic and therapeutic capabilities into a single agent 
for clinical applications, to develop more specific and even 
personalized therapies for various diseases. The rationale arises 
from the fact that diseases, such as cancer, are immensely 
heterogeneous, and all existing treatments are effective for limited 
patient subpopulations and only at precise stages of the disease 
development. The hope is that a close marriage of diagnosis, 
including genome interpretation, and therapy could provide more 
specific therapeutic protocols for each individual and, therefore, 
more likely to offer improved prognoses. The emergence of 
nanotechnology offers an opportunity to draw diagnosis and therapy 
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closer. Imaging nanoparticles and, parallel, nanomaterials for 
therapeutic application have been lively investigated in the last 
years, and the know-how in the field is now exploited in many 
laboratories worldwide to design theranostic nanoparticles, that is to 
say nanoplatforms which can allow a close monitoring of the region 
of interest not only before or after, but also during treatment11.  
Liposomes, gold, silver, iron (magnetic) and silica nanoparticles are 
only few examples of the many substrates investigated nowadays 
for theranostic purposes. Nanomaterials as diagnostic tools are, 
instead, already in clinical trials in many modern imaging techniques 
such as: magnetic resonance imaging (MRI), computed X-ray 
tomography (CT), positron emission tomography (PET), single-
photon emission computed tomography (SPECT), ultrasound 
imaging (US) and optical imaging (OI) 12–15.  
 
Figure 1. Schematic representation of a multifunctional system for 
nanomedicine16. 
OI techniques can find applications in many fields from the surgical 
practice to the molecular investigation of different phenomena. 
Scientists take advantage of OI as tools for in vitro and in vivo 
investigations, in particular for soft tissue, for biological or hard 
technological materials, and they mainly exploit fluorescence-based 
techniques since the input energies, used to gain a highly resolved 
signal in space and time (from the nanoscale up to an entire organ, 
from femtoseconds up to hours), in most cases are not destructive 
and safe.  
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However, in vivo fluorescence optical imaging shows some 
limitations for deep tissues investigation since the penetration depth 
of light is quite low (only around two centimeters) and suitable only 
for soft tissues. This can be, therefore, an election technique for 
superficial skin diseases; in fact, it is already in the clinical trial stage 
for melanoma diagnosis. CAs for fluorescence imaging can be very 
useful tools also in surgery practice where they can guide the 
surgeon in the selective removal of the diseased tissue. Moreover, 
depth limitation can be partially overcome, and imaging extended to 
harder tissues as articulations, with photoacoustic imaging, again 
based on light excitation. In this case, a pulsed near infrared laser is 
used to irradiate a contrast agent which is able to produce 
ultrasound waves that are then detected by a medical ultrasound 
scanner17. We can say therefore that in vivo applications of optical 
imaging are still in their infancy, while they provide the best 
spatiotemporal resolution (nanoscale and femtoseconds) for in vitro 
applications due to the present technological level of microscopes, 
lasers, optical fibers and detectors.  For these reasons in this field 
nano-sized objects can allow to increase the signal and to obtain 
functional information which can be hardly provided by other 
techniques10. 
Besides the diagnostic features, theranostic nanomaterials have to 
be able to promote also efficiently targeted therapies.  
In the framework of medicine, nanomaterials are extensively studied 
for cancer treatment applications thanks to the possibility given by 
EPR of their spontaneous accumulation in damaged tissues. 
Indeed, different therapies are presently in study such as 
photodynamic and photothermal therapies or local chemotherapy by 
drug delivery.11,18,19 Photodynamic and photothermal therapies 
exploit the nanomaterials to convert, respectively, the light stimuli 
into the production of reactive species (singlet oxygen, nitrogen 
oxide…) or into an increase of local temperature, both able to kill the 
surrounding cells. For the limitations described above, these 
therapies are proposed for the treatment of quite ‘superficial’ illness 
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(for example dermal diseases) or localized ones.  Drug delivery of 
chemotherapeutic is, on the contrary, a method able to reach and 
treat diseased tissue simultaneously in the whole body. As already 
mentioned, in this case if targeting is not efficient  healthy cells can 
also be damaged, with serious collateral effects.20 Drug delivery 
consists into ferry a pharmaceutical cargo selectively to targeted 
sites drastically reducing critical side effects and tuning retention 
times. This difficult task can be fulfilled by a properly designed 
nanocarrier able to accumulate in the tumor, to locally release the 
drug in a controlled way that therefore can be lethal for the diseased 
tissues but not hazardous for the patient life quality. This main point 
is related to the drug volume to target ratio: in traditional 
administration the drug dose efficacy has to be computed taking into 
account its distribution in the entire body, while for a drug delivery 
system the dose has to be calculated for the volume of the diseased 
tissues. Nanoparticles suitable for drug delivery must be able to21: 
1) hit selectively diseased sites: which can be obtained by 
passive (EPR) or active targeting (peptide, antibody…). 
2) carry on and control the release of a discrete number of 
pharmaceutical agents: this can be achieved by designing ad 
hoc the nanomaterial yielding a structure able to establish 
controlled labile physical or chemical interactions with the 
drugs molecules. 
1.3 Nanomaterials for Cancer treatment 
Theranostic nanomaterials can be used in vitro for the diagnosis and 
the optimization of the treatment and in vivo for cure/monitor 
protocols. To develop more efficient theranostic agents it is 
necessary to induce selective targeting ability toward the desired 
cells or tissues. In the field of cancer treatment the EPR effect, 
studied and proposed by Maeda as an efficient way to hit solid 
angiogenic tissues (that is to say not only tumors but also 
inflammatory tissues22)  is principally associated with fenestrations 
in vasculature. This effect offers one of the most attractive way to 
7 
 
gain a selective accumulation of a nanostructure in a tumor tissue. 
This is an intrinsic property and it is made possible by the abnormal 
vasculature of the angiogenic tissues together with the longer 
circulation time of nanoparticles in comparison with single 
molecules. The selective accumulation of nanostructures is usually 
localized in the interstitial space23.  
 
Figure 2. Schematic representation of the entrapment of nanoparticles 
inside a tumor tissue by Enhanced and Permeability Retention (EPR)23. 
The size of nanoparticles is a key factor for their efficient entrapment 
by EPR effect. This is due to the fact that objects of different sizes 
present very different circulating times, and this means that with a 
proper design of the size and shape of the nanoobject one can tune 
the amount of entrapped material. Objects smaller than 6 nm are 
excreted too rapidly via urine to accumulate in tumor tissues since 
they can pass the nephron membranes in the kidneys (this excretion 
pathway is the best one for optimum body clearance but too fast for 
an efficient delivery). Objects bigger than 100-150 nm circulate for a 
much longer time inside the body, this is constructive for tissue 
accumulation, but it can result in undesired high toxicity by 
bioaccumulation. Therefore, the nanostructure size is a very 
important parameter in the design of targeting materials, but it is not 
the only one since the nanostructure toxicity depends prevalently 
upon the composition, functionalization and properties of its surface.  
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After the localization in the tumor tissue, a theranostic nanoparticle 
must be internalized by cancer cells to carry out its therapeutic 
action.  The parameters which affect cellular uptake depend upon 
the uptake mechanism and must be taken into account in the design 
of efficient theranostic nanomaterials 24,25. Several different cellular 
uptake mechanisms are possible, but in general the internalization 
is influenced by: 
- size and shape 
- surface charge 
- surface hydrophilicity (hydrophobicity) 
In general, these three parameters influence the nanoparticles/cell 
interaction and, consequently, the cytotoxicity, biocompatibility and 
bio-distribution of the material. 
As already mentioned, the size of nanoparticles rules their uptake 
but also their shape can influence not only the membrane trafficking 
but also their intracellular localization25. The other two parameters 
can be discussed together since they can prevent nanoparticle 
aggregation and influence the interaction with the cellular 
membrane. One of the most established way to prevent nanoparticle 
aggregation is by protecting the nanoparticle surface with 
polyethylene glycol (PEG). This polymer allows to increase the 
water solubility, the biocompatibility, it can work as anti-fouling agent 
and, therefore, protects the nanoparticle by undesired interactions 
with the species present in the biological media including proteins 
and other bio-macromolecules. In these media, in fact, nanoparticles 
are generally surrounded by a biomolecular corona which is a 
complex self-organized architecture of protein and biological 
molecules that interact with the surface of the nanoparticle. This 
corona can greatly interfere with the nanoparticles/cell interaction 
and their localization inside a cell, and it can be considered as the 
surface which mediates nano-objects trafficking. For these reasons, 
when designing a nanoparticle for an efficient internalization its 
interaction with the surrounding biological components must be 
carefully considered. Moreover, one could also take advantage by 
the formation of the biomolecular corona and, controlling its 
composition, it could be possible to target nanoparticles to specific 
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cells. According to this strategy, NPs are thought to be surface-
designed to interact with biopolymers, influencing the corona and 
initiating targeted receptor-mediated cellular binding and 
internalization26–28.  
 
1.4 AIM OF THE WORK 
The aim of this work is the development of fluorescent tools for the 
improvement of nanomaterials designed for theranostic 
applications, focusing on platforms based on dye doped Pluronic 
Silica nanoparticles (PluSNPs). For this goal, it is necessary to: 
 
- to investigate the host/guest abilities of these core/shell 
nanoparticles mapping the polarity of their different 
nanocompartments; this knowhow is crucial for increasing the 
drug loading ability and to suitably tune its release; 
- to synthesize PluSNPs specifically designed for drug delivery 
purposes, taking Sorafenib – a lipophilic chemotherapeutic drug 
– as model; 
- to check the effects of the drug-nanoparticle system in vitro as 
tumour angiogenic controller; 
- to study and optimize the interaction of PluSNPs with macro/bio-
molecules, taking hyaluronic acid (Hya) – one of the chief 
hydrophilic components of the matrix – as model compound; 
- to study and control the effects of their interaction with HyA on 
the cell internalization of PluSNPs; 
- to study a novel fluorescence cross-correlation based imaging 
method (2D-pCF), developed at the Laboratory of Fluorescence 
Dynamics, University of California, Irvine, to map the dynamical 
processes and the trajectories of fluorescent nanostructures in 
cellular environments; 
- to apply this technique, that, in principle, can be very interesting 
for the investigation of cellular internalization phenomena which 
involves fluorescent molecular and/or nanostructured materials, 
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to the investigation of the motion of a fluorescent protein 
involved in the repair mechanism of a DNA damage. 
To summarize, the fundamental theme of my research work is the 
development of luminescent core/shell silica nanoparticles as 
theranostic nanomaterials. For a proper design it is fundamental a 
precise characterization and a deep understanding of their 
performance in a biological environment.  To these goals I have 
tested and optimized fluorescence-based techniques as powerful 
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LUMINESCENT SILICA NANOPARTICLES  
2.1 Introduction 
Luminescence is a very sensitive technique that allows a detection 
down to the single molecule and offers submicron visualization and 
sub millisecond temporal resolution. The development of new 
systems that use luminescence-related techniques1,2 to collect 
molecular level information about biologically relevant processes 
needs to overcome many of the typical limitations of conventional 
luminophores - mainly organic dyes - such as poor photo-stability 
and water solubility, low quantum yield and aggregation under 
physiological conditions3. In this context, nanotechnology leaded to 
the design of platforms taking advantage of many classes of 
nanoparticles - organic, inorganic and metallic - which are currently 
used as fluorescent emitters, each presenting its own pros and cons. 
Probably the main distinction within luminescent nano-system is 
between dye doped nanomaterials and intrinsically luminescent 
ones: according to this broad classification luminescent dye-doped 
latex nanoparticles and quantum dots (QDs) are the most studied 
examples in the literature 4,5,6. Another very promising and versatile 
example of dye-doped luminescent systems are, however, silica 
nanoparticles, and in the next paragraph we will describe their 
principal features and bioanalytical applications.  
 
2.2 Silica Nanoparticles in Nanomedicine 
One of the most interesting and promising chemical matrix useful to 
develop theranostic nanostructures is silica, because its synthetic 
methods allow the fabrication of complex nanoarchitectures where 
size and the surface properties can be modulated to control possible 
interactions with biomolecules, a promising efficient cell 
internalization and specific tissues accumulation 7,8.  Silica 
nanoparticles are composed by an amorphous lattice of silicon 
oxide, usually synthesized by sol gel processes that involve a silica 
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precursor (tetra-alkoxysilane derivatives). Their synthesis can be 
manipulated to obtain structures with different sizes (5 nm – 1 µm), 
porosity and shapes (disk, rod, spherical particles, hollow 
spheres…). Several different morphologies of silica nanoparticles 
are under investigation in clinical and preclinical tests, aimed for the 
evaluation of the cytotoxicity and the biocompatibility by oral or 
subcutaneous administration. For example, a special kind of silica 
nanoparticles developed by the group of Professor U. Wiesner, 
called Cornell Dots, are today used in first stage clinical trials for 
lymph node mapping in cancer patients. These particles comprise a 
targeting moiety, an antifouling polymer layer (PEG, polyethylene 
glycol), and an internal silica core labelled with a near-infrared (NIR) 
fluorescent dye. The diagnostic feature of Cornell Dots is provided 
by a fluorescent label - frequently an alkoxysilane Cy5 derivative - 
which is chemically entrapped inside the silica core. 9,10.  
 
2.3 Synthesis of Dye Doped Silica Nanoparticles 
The synthesis of silica nanoparticles in solution can be obtained 
using sol–gel processes11 under various conditions that lead to 
different materials by tuning parameters such as the catalytic 
conditions and nanoparticle nucleation and growth confinement. All 
these synthetic strategies, however, usually share tetraethoxysilane 
(TEOS) as their silica precursor and characteristics such as 
simplicity, low cost, versatility and control over nanoparticle 
dimensions. The reaction kinetics of silica precursor depends on the 
lengths of the alkoxy moieties of the silica precursor (smaller means 
faster) and the acid or alkaline catalysis which can influence the 
hydrolysis and condensation processes that lead the formation of 
the silicon oxide matrix. The main synthetic approaches are the 
Stöber–Van Blaaderen method and those involving hydrolysis and 
condensation confinement, known as reverse microemulsion 
(water-in-oil)12 and direct micelle assisted methods (Fig. X)13,14. 
Each synthetic approach has advantages and limitations that are 
transferred to the resulting nanostructures, designed to suit 
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particular applications. As a general indication, the use of 
trialkoxysilane derivatized dyes15 ensures condensation of the 
fluorophores within the silica matrix, preventing the leaching of dye 
from the particles. The number of molecular dyes that can be used 
for NPs doping is quite high but can be limited by the synthetic 
strategy. Limitations are mainly related to solubility in the reaction 
milieu and to the synthetic accessibility of the trialkoxysilane 
derivatives. Another important point is the electrostatic interaction 
between the dye and the silica matrix which generally favors the 
inclusion of positively charged dye and hampers negatively charged 
species. In the case of diagnostic applications, the combination of 
several factors such as the brightness of the system, spatial control 
over nanoparticle functionalization and the colloidal stability of the 
nanoparticle suspension determines the suitability of the synthetic 
method. 
Table 1. Main fluorescent Silica nanoparticles synthetic methods: 
versatility (★ = poor; ★ ★ ★ = very good). 
  
 
2.3.1 Stöber Van Blaaderen synthesis 
 




This method is far from dated, thanks to an accessible dimensional 
range spanning from 10 to several hundreds of nanometers (with 
one-pot procedures), very simple synthetic mixtures (TEOS, water 
and ammonia), mild conditions and the possibility to obtain very 
monodisperse NPs. In this strategy, TEOS hydrolysis and NP 
formation are promoted by ammonia and water using ethanol as the 
TEOS co-solvent. The dimension of NPs can be controlled by 
varying the concentrations and ratios of the components. Covalent 
doping of the NPs is achieved by using alkoxysilane derivatized 
dyes, with some limitations due to their solubility in ethanol–water 
mixtures. The luminescence properties of these systems depend on 
the mutual position of the condensed fluorophores within the 
nanoparticle. The Cornell Dots synthesis is an evolution of the 
Stöber methods where a dye rich core works as seed for the 
heterogeneous nucleation of the silica.  
 
2.3.2 REVERSE MICROEMULSION 
 
 
Figure 4. Schematic representation of the reverse microemulsion 
method 
An appropriate mixture of a surfactant and a hydrocarbon induces 
the formation of a dispersion of reverse micelles, capable of housing 
a finite amount of water forming a macroscopically isotropic reverse 
microemulsion (water-in-oil)., The water cores of a reverse 
microemulsion can be exploited as nano-containers to confine a 
Stöber synthetic process. Several protocols of this kind have been 
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proposed to give quite simple access to nanoparticle preparation 
and surface modification in the dimensional range of circa 15–200 
nm14, where the dimension depends largely upon the surfactant type 
and the surfactant-to-water molar ratio 16. This synthetic approach is 
usually appropriate for positively charged water soluble dyes15,17,18, 
since they can be easily incorporated into the reverse microemulsion 
water cores and retained within the nanoparticle silica matrix by 
electrostatic interactions. This prerequisite constitutes a very strong 
limitation to the synthesis of fluorescent nanoparticles doped with 
water insoluble fluorophores or negatively charged ones. 
 
2.3.4 DIRECT MICELLE ASSISTED METHOD 
 
 
Figure 5. Schematic representation of micellar assisted method 
In this synthetic approach, surfactant aggregates or co-aggregates 
in water are used as self-organized templates to confine the growth 
of the silica nanoparticles19. This is possible because of the lipophilic 
nature of silica precursors such as TEOS or other organo-
alkoxysilane; a large range of organic dyes can be used as doping 
molecules using this approach. The general strategy involves a 
water solution of a low molecular weight surfactant (sometimes 
together with a co-surfactant) and a condensation process driven by 
ammonia that leads to monodisperse nanoparticles with a diameter 
from 5 to about 90 nm20,21, a range that is particularly suitable for in 
vivo and in vitro applications. After the formation of the 
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nanoparticles, the colloidal suspension usually undergoes 
purification, usually performed by dialysis, ultrafiltration or 
centrifugation to remove surfactants, silica oligomers and non-
trapped dyes. The nanoparticles investigated in this work are made 
by this synthetic approach, using a high molecular weight surfactant, 
conferring to the nanoparticles peculiar structure and characteristics 
that are reported in the next paragraph.  
 




Figure 6. Dye doped Pluronic Silica Nanoparticles (PluSNPs), a 
schematic overview. A) TEM image and core size distribution. B) 
DLS Hydrodynamic size distribution 
Prodi et al. in the last decade propose a very interesting dye doped 
silica core - PEGylated shell nanostructure (PluSNP) matching most 
of the requirements useful for theranostic applications: as bio-
compatibility, good body-clearance and size suitable for an EPR 
based drug delivery system. PluSNPs with remarkable 
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luminescence properties can be synthesized by chemical 
functionalization of their silica core with alkoxysilane derivatized 
fluorescent molecules. In the final material the silica core protects 
the embedded dyes from quenching and photobleaching agent 
extending their photo-stability and emission efficiency, gaining super 
bright nanoparticles. For these reasons, PluSNPs are already 
investigated as promising fluorescent probe in vivo as well as in vitro 
because they can be administrated safely by subcutaneous or 
intravenous injection or they can be incubated in a cell culture 
showing any side effects and negligible cytotoxicity. Moreover, the 
biocompatibility is due to the core/shell structure of the nanoparticle, 
because PluSNP is composed by a Pluronic F-127 shell, a PEG-
PPO-PEG (hydrophilic PEG=polyethylene glycol, hydrophobic 
PPO= polypropylene oxide) biocompatible block co-polymer. The 
shell is partially entrapped in the porous silica core of 10 nm 
(measured by TEM, Transmission Electron Microscopy). PluSNPs 
show a monodisperse hydrodynamic size of 25 nm which increase 
slightly in protein containing media, showing that the Pluronic shell 
is effective in preventing protein adhesion and nanoparticles 
aggregation in demanding environment like blood plasma or serum 
or in any cellular culture media. These interesting nanostructures 
are synthesized via a micellar assisted route where Pluronic F-127 
works as a surfactant and the Pluronic aggregate become a special 
kind of template where the hydrolysis and condensation of a silica 
precursor (TEOS or TMOS) can occur. This complex 
nanoarchitecture is originated by the entrapment of the Pluronic 
F127 filaments, providing the nanoparticle with a complex shell 
where hydrophilic and hydrophobic moieties co-habit. The shell 
compartment can be efficiently used to host many lipophilic 
molecules, such as fluorescent dyes or metal ion fluorescent 
biosensor, showing that this nanostructure is interesting and 
promising as intracellular carrier for drug delivery purposes22–24.  
 
2.4.1 DYE DOPED PluSNPs - BIOLOGICAL APPLICACTIONS - 
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The colloidal behavior in biological environment and the cell 
interactions of PluSNPs can be controlled by managing some 
nanoparticles charge properties (affecting their Z-Potential). Two 
main strategies are possible, acting on:  
- the core charge, using the silica precursor combined with 
charged silane derivatives bearing ammonium or carboxylate 
moieties; 
- the shell, upon transformation of the Pluronic F-127 hydroxyl 
groups into carboxylic acid or amine moieties.  
In this paragraph are briefly described some example of biological 
application of PluSNPs as fluorescence label where the surface 
properties influence their biological activity.20 
In 2013 Prodi et al. showed a very interesting application of dye 
doped PluSNPs for the NIR imaging of sentinel lymph nodes. This 
investigation was carried out tuning the surface charge of the 
PluSNPs by two different strategy: i) the modification of the negative 
charge within the core by using CETS (Carboxy Ethyl Trihydroxy 
Silanol) or ii) by the insertion of carboxylate groups on the 
nanoparticle shell using carboxy derivatized Pluronic F-127. 
Different amounts of negative charge groups were tested, evaluating 
the trends of hydrodynamic size and the ζ-potential of different 
nanoparticles samples. The nanoparticles were doped with a 
Cyanine 7 NIR emitting dye, modified with a triethoxy silane group 
to have covalent link of the dye within the silica core. Fluorescence 
in vivo imaging investigation on mouse showed how different 
surface charge modification strategy influenced deeply the kinetics 
of accumulation and visualization of right axillary lymph node 
(RALN). The cause of such differences was attributed to a synergy 
between ζ-potential and size in physiological conditions. This 
hypothesis, was verified toward aggregation experiments between 






Figure 7. A) Schematic Representation of Cyanine 7 doped 
PluSNPs presenting negative charges within the core (introduced by 
CETS) and on the shell (using dicarboxylic modified Pluronic F-127 
CARBO surfactant). B) Hydrodynamic size and ζ-potential of 
different samples containing increasing amount of CETS or F-127 
CARBO. C) In vivo fluorescence intensity of RALN at different post-
injection time. Mice were subcutaneously injected in the right 
anterior paw. Fluorescence imaging of RALN was performed at 
different times after injection with a 739 nm excitation light. 
PluSNPs with negative charges on the shell showed a more 
pronounced aggregation behavior in the presence of BSA, with 
strong effects on their hydrodynamic diameter. On the other side, 
nanoparticles presenting a modified silica core were less prone to 
aggregation in the presence of BSA, with a hydrodynamic size 
always less than 60 nm, also in rich protein environments. PluSNPs 
with negatively charged core were then considered as the sample 
with the best overall performance in RALN mapping, probably 
23 
 
because of the more negative ζ-potential and less steep aggregation 
profile in the presence of BSA. These results clearly indicated that 
for SLN mapping the NP architecture in which the COOH groups 
(necessary to confer a negative ζ-potential) are buried in the PEG 
shell was more efficient than the one in which the same groups were 
outstretched from the surface of the NP.  
 
Figure 8. Hydrodynamic diameters (DLS) of NPs-COOH shell, NPs-
COOH (2) and (4) core, and NPs-COOH core in the presence of 
increasing amounts of BSA. (NPs-COOH core (2) and (4) have two 
different amounts of COOH per nanoparticles respectively 4.5 and 
18.) 
The evolution of the effect of the rich protein environments on 
migration of a nanoparticle to a target tissue is a clear example on 
how the biomolecular corona can influence the colloidal behavior of 
this kind of nanoparticles in different tissues or via different systems 
(lymphatic, vascular…) 
In another example, the influence of the PluSNPs surface chemistry 
was studied to evaluate effects on the endocytosis and to evaluate 
the interaction with lipid bilayer.  
Surface charge of a nanostructures is responsible, in general, of 
nanoparticle/cells interaction. For PluSNPs positive surface charge 
can enhance the uptake by endocytosis due to the anionic charge 
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of cellular membranes. Moreover, the internalization of PluSNPs by 
JVM-2 B leukemic line in suspension, and of Hu7 cells in adhesion 
was promoted preferentially by caveolae-mediated pathway. 
Endocytosis mainly proceeded firstly by the interaction of 
nanoparticle with the cell membrane which can stimulate the 
formation and internalization of a vesicle24.  
The development of tools or techniques giving access to information 
at nanoscale level regarding  interactions between nanoparticles 
and complex interfaces as the cellular membrane are highly 
desirable, since they can help to rationalize the design of fluorescent 
nanoparticles for imaging and theragnostic applications A practical 
example was provided using an energy transfer approach (which 
occur between a donor and an acceptor only when they are very 
close, range about 10 nm, see Appendix) between PluSNPs with 
different charge and a dye labeled lipid bilayer. This tool permitted 
to describe the interaction in vitro, looking the energy transfer in 




Figure 9. I) Schematic representation of PluSNPs with different 
charge and the dye labeled lipid bilayer. II)  Emission spectra of 
different surface charge PluSNPs and different kind of lipid bilayer 
and their relative Energy Transfer efficiencies. III) investigation 
intracellular energy transfer of PluSNPs and lipid bilayer.  
By changing the surface properties of the nanoparticles it was 
possible to drive their interaction with biological compartments, to 
increase for example the accumulation in lymph node or to enhance 
the cellular uptake by endocytosis22–24. These investigations 
showed how the nanoparticles in the biological media can form a 
bioinorganic interface which can control many aspects of the 
PluSNP bioavailability. The PluSNPs surface composition seem to 
be very important to develop tools able to understand and model the 
interaction between nanoparticle and biomacromolecules. A 
solution to prove the interaction of PluSNPs with biomacromolecules 
can be provided by fluorescence, a technique able to demonstrate 
nanoparticle-macromolecule interactions for examples exploiting 
the colocalization of two fluorophores (Energy Transfer). 
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Fluorescence is also able to map nano-polarities (solvatochromism) 
and to observe the motion of nanoobjects in solution as well as in 
complex systems as the cellular media (Fluorescence Correlation 
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Shell Nanopolarities of Pluronic Silica nanoparticles 
Polarity and proticity of confined nanoenvironments are able to tune 
the strength of noncovalent interactions such as H-bonds, 
electrostatic and van der Waals interactions or π- π stacking; as 
such, they play a fundamental role in many chemical and 
biochemical processes that are driven by local environmental 
heterogeneity, such as enzymatic catalysis,1-4 molecular 
recognition, self-assembly of polymers, micelles and vesicles,5 
molecular transport and delivery,6 and bottom-up formation of 
nanostructures and nanomaterials.7-10 
Nanomaterials are expressing a rich potential in as much as they 
can implement such polarity heterogeneity at the nanoscale, 
featuring several environments with different physicochemical 
properties in a single structure. This richness, which can be 
compared to the complexity of biological species such as proteins 
and DNA, is at the basis of their peculiar versatility and of their ability 
to perform complex functions, such as drug delivery and targeted 
transport,6, 11-13 adsorption of pollutants,14 adhesion and colloidal 
stabilization.15-16 
Despite the extensive production of novel nanomaterials composed 
of several compartments with different polarities,13, 17 the 
characterization of polarity distribution in such a confined space is 
difficult and often remains an assumption based on chemical 
structure and morphology of these nanoarchitectures. Fluorescent 
solvatochromic dyes have been used in seminal works to investigate 
polarity of micelles and vesicles.18-19 Similar information could also 
be sought for more elaborate nanomaterials composed of multiple 
domains. Nonetheless, the complexity of such architectures makes 
it difficult to obtain a correct description of the multiple 
nanoenvironments, and to distinguish which environment is actually 
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being probed by the dye. The current models used to describe 
micropolarity, based on the Kamlet-Taft parameters, provide only an 
average description of polarity and proticity of the 
microenvironments.20-29 Some efforts have also been done to isolate 
the contribution of the bulk solvent.30 A correct description of 
complex multicompartment nanostructures, on the contrary, 
requires to find unambiguous interpretation of multi-component 
fluorescence data. In this contribution, we describe a method based 
on spectral deconvolution and FRET analysis that yields polarity 
mapping of complex nanoarchitectures.  Our approach overcomes 
the limits of current methods based on Kamlet-Taft parameters, 
since it allows to simultaneously quantify and visualize a wide range 
of polarities featured by the nanomaterial, and in addition it yields 
space-correlation of polarity and proticity information from 
compartments located few nanometers apart. In a first step we 
perform spectral deconvolution of the emission spectra of 
solvatochromic fluorescent probes: the complex spectrum of each 
solvatochromic probe in a multicompartment nanostructure is fitted 
using a set of spectra of the same probe in pure solvents, yielding 
coefficients that quantify the fraction of dyes probing similar polarity 
as that of the pure solvents inside the nanostructure. The number 
and type of solvents used for the fitting set determines the resolution 
of the technique and should be adequately chosen according to the 
polarity gradient to be explored and quantified. With the second 
step, the method allows to reconstruct the approximate distance 
between probed compartments: this result is achieved upon careful 
selection of at least two solvatochromic fluorescent dyes with 
suitable photophysical features and exploiting the occurrence of 
energy transfer from and to the probes. The multiple FRET 
contributions are sorted by polarity via spectral deconvolution. As a 
result, estimation of energy transfer efficiency for each individual 
spectral component of the probes yields fine mapping of 
nanoenvironment polarities within the nanostructure. We test this 
method by investigating a multilayer nano-architecture composed of 
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a silica core grown into a micelle of triblock copolymer Pluronic 
F127, previously named “PluS NPs”.31-32 It has been shown that this 
nanomaterial is composed of a dense silica core and of a soft 
polymeric shell, which among other things is responsible for the long 
term colloidal stability in water, and for the ability of these 
nanoparticles to host hydrophobic moieties close to the internal 
silica core.33-34 The shell should hence display both hydrophobic 
hosting sites and a hydrophilic surface ensuring favorable 
interaction with external water (figure 1 and figure Technical Notes 
1). Despite the large knowledge on structure, behavior and abilities 
of this nanoarchitecture, the intimate distribution of its environments 
with different polarity and proticity still remains to be elucidated. 
Previous knowledge on morphology and on chemical properties of 
the components suggests a possible model for the nanoarchitecture 
that consists of a dense silica shell, in which the hydrophobic 
polypropylene oxide (PPO) segments are deeply buried, and of a 
permeable soft polymeric shell.31, 33, 35 The shell itself might be 
composed of two sections: a hydrophobic inner layer close to the 
silica, made of PPO (the part that is not completely buried in the 
silica network) and an outer layer made of the PEG terminations, 





Figure 1 – Cartoon of multicompartment nanostructures PluS NPs 
(left and center) probed by the luminescent solvatochromic dyes P 
and NR (right). Letters a-d indicate the compartments presumed 
from the known morphology, specifically: a) dense silica core 
embedding PPO chains; b) PPO brushes emerging from the silica 
core; c) interfacial region with PPO and PEG; d) external layer with 
PEG brushes. 
We select two well-known solvatochromic probes, i.e. Nile Red (NR) 
and Prodan (P) owing to their respective polarity and spectral 
features. They share a distinct preference for hydrophobic 
environments, even though they are partly soluble and emissive in 
polar solvents, with P in particular providing an appreciable signal 
also in water (see table 1). Furthermore, the emission spectra show 
almost no overlap, even accounting for the whole range of polarities 
that can be explored by each probe (figure 2), which allows for 
sensitive quantification of all polarity-dependent signals owing to the 
very low crosstalk. Finally, Forster Radius R0 for P-NR couple is 
quite large and almost constant for all combinations of 
environments, due to the fact that spectral overlap increases in polar 
solvents, where quantum yield of the donor decreases (see table 2): 
the uniform R0 allows to trace back the distance between different 
compartments via accurate estimation of FRET efficiency between 
dyes. The probes were added to the solution of NPs via addition of 
small aliquots of a concentrated acetonitrile solution (1 mM), which 
did not interfere with the nanoarchitecture. Neither of the two probes 
displays aggregation in the concentration range used in this study, 
therefore reported spectral observations are unequivocally ascribed 
to change of polarity and proticity of the nanoenvironment. 
 
3.1 SPECTRAL FITTING 
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Quantification of number and polarity of probed hosting sites is a key 
step of this work. First, we measure the emission spectra Si(λ) of NR 
and P at a fixed concentration in a set of 5 reference environments 
i (the pure solvents toluene, dichloromethane, acetonitrile, methanol 
and water, respectively indicated as t, d, a, m, and w), covering a 
broad range of polarities and protic levels. Then, we use such 
reference spectra Si(λ) to fit the emission spectra of NR and P in the 
multicompartment nanostructure PluSNP(λ): this yields the 
coefficients ci that quantify the fraction of dye probing the polarity 
and proticity of the ith environment (eq. 1). 
𝑃𝑙𝑢𝑠𝑁𝑃(𝜆) = ∑ 𝑐𝑖𝑆𝑖(𝜆)
𝑛
𝑖=1  (eq. 1) 
It has to be noted that the complex information obtained with this 
method is highly reproducible and that it can also be obtained for 
other nanostructures, opening the way for quantitative comparison 
of polarity and proticity of nanomaterials, not limited to description of 




Figure 2 – Absorption (dashed lines) and emission spectra (solid 
lines) of P (a) and NR (b) in toluene, dichloromethane, acetonitrile, 
methanol and water (bands shifting from left to right respectively). 
All spectra are normalized; note that intensity of Nile Red emission 
in water is extremely weak compared to other solvents (see 
quantum yields in table 2) The not-normalized emission spectra are 
used in equation 1 as St(λ), Sd(λ), Sa(λ), Sm(λ), and Sw(λ) (Figure 2 






3.2 SOLVATOCHROMIC, ENERGY TRANSFER 
Table 2 Photophysical data for the probes P and NR in the five 
solvents used in this study, i.e. toluene (t), dichloromethane (d), 
acetonitrile (a), methanol (m) and water (w). 
 QY% τ / ns λem,max /nm λabs,max /nm ε / M-1cm-1 
PRODAN 
t 56 2.21 414 348 18400 
d 98 3.20 438 353 24600 
a 95 3.30 456 350 21400 
m 77 2.57 501 360 19500 
w 25 0.98 524 359 13200 
NILE RED 
t 80 3.97 566 535 29500 
d 78 4.52 600 538 35500  
a 76 4.63 613 556 38600 
m 40 2.76 633 526 32800 
w 0,5 0.55 660 588 14400 
 
Table 3. – Forster Radii (Angstrom) for the FRET pair P-NR in the 
investigated solvent combinations 
R0 
PRODAN 
t d a m w 
NILE RED 
t 29.7 40.7 43.6 46.4 37.2 
d 29.1 40.0 43.3 47.9 39.7 
a 29.1 40.1 43.5 48.3 40.1 
m 26.7 37.1 40.6 46.5 39.5 
w 24.5 33.4 36.0 40.8 35.0 
 
Both NR and P, when added in small amounts to a water solution of 
Plus NPs (1*10-6M), find a heterogeneous variety of hosting sites to 
occupy and therefore generate complex and multicomponent 
signals. The information obtained by the two probes is 
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complementary since they exhibit different spectral responses and 
cover different ranges of polarity. The gradual shift of the emission 
maximum displayed by NR upon increasing its concentration in 
presence of PluS NPs reveals that polarity of populated hosting sites 
shifts progressively from an environment similar to toluene to one 
comparable to methanol (see normalized emission spectra in figure 
3b, not normalized spectra are reported in figure SI3). On the other 
hand, P displays a peculiar emission spectrum with two well 
separated bands, which respectively report on aprotic (higher 
energy emission band) and protic microenvironments (lower energy 
emission band).18-19 Interestingly, each band is also sensitive to 
polarity, so that it is possible to distinguish between strongly and 
mildly apolar environments (corresponding to toluene and 
dichloromethane in our set of 5 solvents references) and between 
mildly and strongly hydrophilic sites, up to a purely aqueous 
environment (acetonitrile, methanol and water, see figure 3a). 
Differently from NR, P displays even at the lowest concentration a 
significant contribution of polar protic environments (lower energy 
band), whose weight increases with P concentration and that 
concomitantly shows a relevant bathochromic shift (figure 3a). 
Coefficients found upon fitting the experimental emission spectra 
of P and NR show comparable trends: coefficients of toluene and 
dichloromethane (ct and cd) show an initially high slope (indicating 
efficient population of hydrophobic hosting sites) which decreases 
until reaching a plateau at high probe concentration, indicating that 
such hydrophobic sites are soon saturated by the probes. On the 
other hand, the more hydrophilic hosting sites, which are here 
monitored via the coefficients of acetonitrile and methanol (ca and 
cm respectively) are able to host a larger number of dyes: the 
coefficients ca and cm overcome ct and cd respectively, when these 
latter go towards a plateau. This analysis thus shows that the two 
solvatochromic probes P and NR are first hosted by both hydrophilic 
and hydrophobic sites of PluS NPs, with a preference for 
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hydrophobic sites; then, at higher probe concentration, hydrophobic 
sites are saturated, and the probes largely populate hosting sites 
that are as hydrophilic and protic as methanol environment. P also 
feature a rather large coefficient for water (cw) since the very first 
additions, which deserves separate considerations (see trend of cw 
in figure 3). P is indeed clearly reporting on a water-like 
microenvironment: this might correspond to either a water pocket 
inside the PEG shell, or simply to bulk water outside PluS NPs.  
 
Figure 3 – Normalized emission spectra of titration of Plus NPs 
with P (a) and NR (b) and fitting coefficients of the spectral 
components relative to toluene (ct, black), dichloromethane (cd, red), 
acetonitrile (ca, green), methanol (cm, yellow) and water (cw, blue), 
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obtained from the not-normalized emission spectra of titration of 
Plus NPs with P (c) and NR (d). 
The presence of water molecules inside the PEG shell is crucial for 
many applications of PluS NPs and of PEG stabilized 
nanostructures in general: they can for instance be involved in 
catalytic reactions taking place in the nanocompartment, they can 
stabilize or decompose hosted drugs, they can regulate kinetics of 
delivery or transport and permeation of small molecules and ions 
inside nanostructures.36-37 To determine whether the polar protic 
environments (here quantitatively described by coefficients cm and 
cw) are reporting on hydration molecules inside PEG shell or on bulk 
water outside the PluS NPs, we developed an approach based on 
FRET between different solvatochromic probes, which 
unambiguously localize the hydrated compartments relative to the 
hydrophobic ones. To this aim, we loaded 5*10-6M P in Plus NPs, 
corresponding to 5 P dyes per NP, so that environments probed by 
the donor P dyes in these conditions cover all polarities, including 
water. Then, we added increasing amounts of NR to this system, 
following its localization via its selective excitation at 520 nm (Figure 
11 Technical Notes). Interestingly, upon addition of NR and direct 
excitation of P at 330 nm, we observe a pronounced quenching of P 
emission and a concomitant sensitization of NR. This preliminary 
observation confirms that the two probes are located in 
compartments within the same nanostructure and thus close enough 
to transfer energy quite efficiently, also owing to their rather large R0 




Figure 4 –Normalized emission spectra (a) and fitting emission 
coefficients (b) of FRET titration of PluS NPs and P (5*10-6M) with 
increasing amounts of NR (from 0.1 to 12*10-6M). 
Beside this general observation, the spectral deconvolution 
method here developed allows to resolve the various polarities 
probed by P and NR, and consequently to resolve FRET efficiency 
as a function of the microenvironment. This procedure opens the 
way to a fine understanding of the system, since it reveals whether 
P is transferring energy to NR from all probed compartments, 
including the hydrated (protic) ones, quantitatively described by cm 
and cw. We analyze the quenching of P after separating its complex 
emission spectrum in the 5 components and then we follow the trend 
of the coefficients, with particular attention to cm and cw. 
Interestingly, while the coefficients ct, cd, ca and cm are heavily 
depleted by the increasing concentration of NR, cw is independent 
on it and remains substantially constant (Figure 4b). This analysis 
leads to two important findings: first, 4 very different 
nanoenvironments in terms of polarity and proticity are very close to 
each other, within few nanometers distance (toluene, 
dichloromethane, acetonitrile and methanol); in particular, a 
compartment of PluS NPs features polar protic hosting sites 
(methanol nanoenvironments), which can be ascribed to PEG 
branches hydrated by a restricted number of water molecules; 
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second, the “water-like” compartment probed by P is far away from 
the other hydrophobic and hydrophilic sites hosting the NR dyes, 
and can therefore be ascribed to bulk water, external to the 
nanostructure; therefore, no water pockets are detected by P inside 
the nanostructure. 
Finally, the method allows to perform an analogous polarity-
resolved spectral analysis of FRET on the acceptor, NR. 
Deconvolution of directly excited NR spectra (λexc = 520 nm) and of 
sensitized NR spectra (i.e., excited via FRET from P, λexc = 330 nm) 
provides coefficients of environments probed by NR and coefficients 
of the environments in which NR accepts energy from P, 
respectively. Quantitative comparison of such coefficients reveals 
that all components of NR are equally sensitized by P, confirming 
that all emissive NR probes are distributed inside the various 
compartments of PluS NPs –from apolar (ct and cd) to polar (ca) and 
polar protic ones (cm) – (Figure 11 Technical Notes). 
The highly informative results collected with this method 
demonstrate that the two-compartment model (silica core / PEG 
shell) used so far to describe the Plus NP architecture is by far too 
simplified. A variety of nanoenvironments were probed and localized 
within the nanostructure, featuring very different polarity and 
proticity. A more rigorous description of the system should hence 
consider a small apolar region (matching with the inner layer of 
dense, not hydrated PPO), and an increasingly polar layer 
(ascribable to the PEG branches) with a volume able to host tens of 
dyes. The polar layer reaches, in the outer part, a very high polarity 
and proticity, comparable to the ones of methanol: this finding allows 







In conclusion, we developed a new method to investigate the 
multifaceted polarity and proticity of complex nanostructures, with 
the unique ability of co-localizing the different probed environments.  
The method is based on the use of at least two solvatochromic 
fluorescent probes with suitable photophysical properties (including 
similar R0 for all combinations of environments) to efficiently 
exchange energy via FRET. These species can hence (i) report on 
multiple environments to be found in the nanoarchitectures, and (ii) 
colocalize the various environments via FRET. The method has 
been tested here on a well-known multicompartment nanomaterial 
–PluS NPs– using two solvatochromic probes –Prodan and Nile 
Red–. I found a wide range of polarities, ranging from apolar, to 
polar, and also to polar protic nanoenvironments, within R0 distance, 
ascribable to dense PPO, PEG and to partly hydrated PEG 
branches respectively. In addition, it was possible to experimentally 
prove that the component similar to water does not belong to the 
nanostructure, but it is merely due to bulk water. 
This simple method is general and can be applied in a versatile, 
modular fashion to a broad range of nanomaterials. We believe that 
it could be of inspiration for a wide scientific community involved in 
fabricating, investigating and using nanostructured materials, since 
understanding polarity distribution in these systems is essential to 
grasp their potential in a variety of fields and applications, ranging 
from their use as nanoreactors and artificial enzymes, to molecular 






3.4 EXPERIMENTAL METHODS 
Synthesis of PluS NPs: Plus NPs are synthesized as reported in 
previous papers.32 Briefly, Tetraethylorthosilicate (TEOS, 180 µL, 
0.8 mmol) was added to an acidic aqueous solution (Acetic Acid 1M) 
of Pluronic F127 (100 mg) and NaCl (67 mg) under magnetic stirring, 
and its hydrolysis and condensation was allowed to proceed for 3 
hours. Trimethylsilylcloride (TMSCL, 10 µL, 0.08 mmol) was then 
added and the solution was stirred overnight. So, obtained Plus NPs 
solution was purified via dialysis for at least 4 days, using RC 
membrane (cut off 12 KDa) against water. The solution in the 
membrane was recovered and diluted to 10 ml to obtain a final 
concentration of the nanoparticles of 10 µM.33 The morphology of 
PluS NPs was characterized with DLS and TEM, yielding the 
hydrodynamic radius (Rh = 13 nm, polydispersity index PdI = 0.11) 
and the diameter of the silica core (dc = 11 ± 1 nm), respectively. A 
representative TEM image used for image analysis is shown below. 
Fluorescence titrations of PluS NPs with solvatochromic probes: 
2.5 mL of 1*10-6 M solution of PluS NPs in water was titrated with a 
small amount (1 µL to 50 µL) of a millimolar acetonitrile solution of 
solvatochromic dye (P or NR). Absorption spectra were recorded on 
a Perkin Elmer Lambda45 spectrophotometer, while emission 
spectra were recorded on an Edinburgh F900 fluorometer equipped 
with a photomultiplier Hamamatsu R928P. FRET experiments were 
performed by titrating an aqueous solution of PluS NPs 1*10-6 M and 
P 5*10-6 M with a millimolar solution of NR in acetonitrile. 
Data analysis: spectral deconvolution was performed through the 
fitting algorithm of Sigmaplot (Systat Software Inc., Technical Notes) 
following eq. 1. The input spectra Si(λ) were recorded at equimolar 
concentration of solvatochromic probe in the five selected solvents, 
using constant instrumental conditions and excitation wavelengths 
(λexc = 330 nm for P and λexc = 520 nm for NR). The water component 
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is not used to fit NR emission spectra, due to the very low quantum 
yield and solubility of this solvatochromic probe in this solvent. 
 
3.5 TECHNICAL NOTES 
 
 
Figure 5 TEM micrograph (top) and hydrodynamic diameter 




Figure 6. Emission spectra of equimolar solutions of Prodan (left) 
and Nile Red (right) in the five solvents used in this study (t=toluene, 
d=dichloromethane, a=acetonitrile, m=methanol, w=water). 




The SigmaPlot curve fitter uses the Marquardt-Levenberg 
algorithm to find the coefficients (parameters) of the independent 
variable(S) that give the best fit between the equation and the data. 
This algorithm seeks the values of the parameters that minimize 
the sum of the squared differences between the values of the 






where yi is the observed and yi is the predicted value of the 
dependent variable. This process is iterative the curve fitter begins 
with a guess at the parameters, checks to see how well the 
equation fits, then continues to make better guesses until the 
𝑆𝑆 = ∑ 𝑊𝑖(𝑦𝑖 − 𝑦2)






differences between the residual sum of squares no longer 
decreases significantly. This condition is known as convergence. 
 
Figure 7. Trends of Residuals Integral% (Residuals integral/ 
Experimental Spectrum Integral *100) of the fitting with different 
basis sets for Prodan (black line) and Nile Red (red line) 5 *10-6 M 


























































Figure 8. Display of the fitting combinations for Prodan 5 *10-6 M in 
presence of 1*10-6 M of PluSNPs. From the top to the bottom 
different composition of the basis set for the fitting are showed, in 
particular, from one component A to the five components T, D, A, M 
and W. the black solid line represent the experimental spectra in red 
the fitted one. The dashed black line rapresent the residuals (Fitted-




Figure 9. Display of the fitting combinations for Nile Red 5 *10-6 M 
in presence of 1*10-6 M of PluSNPs. From the top to the bottom 
different composition of the basis set for the fitting are showed, in 
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particular, from one component A to the five components T, D, A, M 
and W. the black solid line represent the experimental spectra in red 
the fitted one. The dashed black line rapresent the residuals (Fitted 
-Experimental spectra).    
 
 
Figure 10. Emission spectra of PluS NPs 10-6 M in water titrated 
with Prodan (excitation wavelength 330 nm, left) or with Nile Red 





Figure 11.  Top graph: Emission spectra of Nile Red added to a 
solution containing PluS NPs 10-6 M and Prodan 5*10-6 M, excited 
directly at 520 nm (red spectra) or excited via FRET through Prodan 
at 330 nm (black spectra). The latter spectra were obtained by 
measuring the overall emission spectra which includes emission 
from Prodan (shown in figure 4), followed by fitting the spectra with 
the nine spectral components (5 for Prodan and 4 for Nile Red), and 
finally subtracting the emission components relative to Prodan to the 
original spectra shown in figure 4, hence yielding uniquely the Nile 
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Red emission. Bottom graphs: fitting coefficients ct, cd, ca and cm 
obtained for emission spectra reported above, i.e. for sensitized 
(left) and for directly excited Nile Red (right). 
 
 
Figure 12. Fluorescence Anisotropy (black line) and Normalized 
Fluorescence Emission intensity (red line) of Prodan 1 and 5*10-6 
M (solid and dashed respectively) added to 1*10-6 M of PluSNPs. 
(λex=330 nm) 
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Figure 13. Fluorescence Anisotropy (black line) and Normalized 
Fluorescence Emission intensity (red line) of Nile Red 1 and 5*10-6 
M (solid and dashed respectively) added to 1*10-6 M of PluSNPs. 
(λex=520 nm) 
 
Figure 104. Time Resolved Spectral Emission of Prodan 1 eq. and 
5 eq. respect to 1*10-6M of PluSNPs (λex=405 nm) 
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Figure 11. Time Resolved Spectral Emission of Nile Red 1 eq. and 
5 eq. respect to 1*10-6M of PluSNPs (λex=405 nm) 
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DRUG DELIVERY OF PluSNPs 
 4.1 DRUG DELIVERY NANOPARTICLES 
The use of nano-based materials for sustained release of drugs 
presents advantages over the use of free drugs. These materials 
can improve the availability of molecules in the body and, when they 
are targeted, can increase the drug concentration in sites of interest, 
thus enabling the use of smaller doses1,2,3. Moreover, 
nanostructured material can allow the formulation and design of 
multimodal agents combining therapeutic and diagnostic tools. 
These systems, referred as theranostic nanomaterials, can be 
developed for the investigation and treatment against invasive 
tumors. Tumor tissues, in general, show abnormal permeability for 
nanostructures because of their abnormal vascularization, so that 
large objects of suitable dimension are physically entrapped. This 
extravasation effect is called enhanced and permeability retention 
(EPR), can be considered as a form of passive targeting of 
nanostructured materials and offer a possibility to vehiculate 
nanocarriers selectively in tumor tissue.  
The kinetics of entrapment can be modulated by controlling the 
surface properties (hydrophilicity, charge, functional groups) and the 
size of the nanoobjects.4 FDA has approved nanomaterials ranging 
from 10 to 130 nm  based on EPR. 5 For smaller objects the EPR 
shouldn’t be effective while bigger ones can be bio-accumulated 
resulting toxic. Here, I proposed a nanoarchitecture based on dye 
doped silica which can be designed for drug delivery application 
combined in a unique structure with diagnostic features. This kind of 
luminescent silica core/Pluronic shell nanostructures are nowadays 
an interesting material because they are biocompatible, 
monodisperse, and the dyes which decorate the silica core yield 
tunable and size independent optical properties5. Recently, these 
dye doped nanoparticles are investigated in in vivo assays as a 
fluorescent agent, for diagnosis as a contrast agent for sentinel 
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lymph nodes and for therapeutic as photo-thermal agent6,7. The 
synthesis of dye doped Pluronic Silica nanoparticle is made with a 
micellar assisted method where the Pluronic F-127 (F-127) micelle 
works as nanoconfined environment where the silica precursor can 
react and form a unique structure. At the end of the synthesis, the 
polymer is entrapped in a porous silica core with a whole diameter 
of 25 nm. The synthesis can be designed, using the micelle as a 
container for huge amount of lipophilic drug which can be partially 
entrapped by the silica core, with a final goal of controlling the 
kinetics of drug release respect to the system composed by Pluronic 
micelles. Polymer micelles have the potential to meet many of the 
requirements and have been extensively investigated for drug 
delivery, for gene delivery, and for carrying various contrast agents 
for diagnostic imaging. As a result, micelles can be used to 
effectively solubilize and carry in the core structure compounds that 
have poor solubility, low stability, or undesirable pharmaceutical 
properties. Micelles as drug carriers are inexpensive to make and 
are available in large quantities. Their small sizes also allow them to 
circulate in the body and accumulate in the affected area with leaky, 
pathological vasculature. The physical stability of the drug carrier is 
however a critical issue. For many applications it is desirable to have 
good stability and keep the pharmaceuticals and contrast agents in 
the blood pool over an extended period. Recent studies have shown 
that the in vivo antitumor activity of a drug incorporated into the 
polymer micelles is positively correlated with the stability of micelles. 
However, micelles may be intrinsically unstable in a natural, 
biological environment, even though some polymeric micelles are 
significantly better in terms of having a higher CMC and a more rigid 
structure. The micelle stability is particularly important for 
applications involving changes in temperature, solution 
concentrations, aggressive physical forces (mechanical shearing for 
example), or competing interactions in in vivo conditions. For 
example, Pluronic block copolymer micelles dissociate readily upon 
dilution. This could be a serious problem because when delivered 
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into body fluids, the surfactant concentration will be diluted by many 
orders of magnitude, possibly to below the CMC. Under these 
conditions, the micelles would disintegrate, and the drug would 
precipitate. The strategy of forming the PluSNPs by hindering the 
structure of the micelle within the formation of a silica core, can thus 
allow taking advantages of the micellar properties and overcome the 
instability limitations.8   
 
The synthesis of Pluronic Silica nanoparticles is made by a micellar 
assisted method where the micelle, for drug delivery purposes works 
as a magazine. Pluronic F-127 micelles are widely investigated as 
carrier for lipophilic molecules.  
In this context, Sorafenib Tosylate, a lipophilic drug for the human 
clinical treatment of renal carcinoma has been chosen as drug 
model (SRF, Figure 1).9 
 
 
Figure 12. Chemical structure of Sorafenib Tosylate 
 
This drug is very insoluble in water, since it precipitates at very low 
concentration (about 10-5 M). If Sorafenib (about 5 mg/ml) is 
solubilized in a F-127 micellar solution (F-127 5mM), the solution 
remains clear up to one hour and half; after that precipitation occurs. 
This behavior allows to design a suitable synthetic strategy for the 
formulation of fluorescent silica nanoparticles which can carry a 
large amount of drug and they are suitable, and can allow optical 
imaging.  




The transient Sorafenib entrapment in the Pluronic F-127 micelles 
offers the possibility to design the synthesis forming the silica core 
before the drug could diffuse massively in the bulk of solution where 
it precipitates. The synthesis of Pluronic silica nanoparticles is 
composed, in a typical synthesis by three principal steps:  
1) The self-assembly of the micelles by Pluronic F-127. The 
kinetics of formation of micelles can take some minutes. The 
solution is kept under stirring until the solid is completely 
dissolved. 
2) The hydrolysis in acidic media and condensation of the silica 
precursor in the nanoconfined reactor of the micelles: the 
most common silica precursor used is Tetraethylorthosilicate 
(TEOS) which is quite stable and, in these conditions, can 
react completely only after two-three hours. This reaction 
kinetics is too long for an efficient entrapment of the drug. 
Since alkoxy silane derivatives show a faster hydrolysis 
kinetics when the length of the alkyl chains is short, we 
choose for these purposes the smallest 
tetramethoxyorthosilicate (TMOS) which, in these conditions, 
can react completely in very few minutes.  
3) The purification usually is carried out with a dialysis 
membrane. This purification method allows to neutralize the 
acidic medium and to eliminate the not reacted species. An 
efficient dialysis, however, takes at least one day, a too long 
period for this purpose since the drug can be released at least 
partially by the NPs.  For this reason, we chose size exclusion 
chromatography (SEC, Sephadex® G-25); using PBS for the 
elution it was possible to neutralize the medium and remove 
the drug/dyes not entrapped in the nanoparticles.   
 
4.3 Synthesis of SORAFENIB LOADED RHODAMINE B 





Figure 13. Schematic representation of the synthesis of PluSNPs/ 
SRF nanoarchitecture.  
 
Experimentally the synthesis of Sorafenib loaded F-127 Silica 
nanoparticles is carried out dissolving 200 mg of Pluronic F 127 and 
19 mg of Sorafenib Tosylate (100 eq. vs 64 µM of Pluronic F-127 
Micelles) in 2 milliliters of methanol in a scintillation vial. This action 
allows to have a perfectly mix of the two components. After the 
removal of the organic solvent under a reduced pressure, 3.3 
milliliters of acetic acid 1 M and 140 mg of NaCl are added. The 
solution is kept under gentle magnetic stirring, and after the 
complete solubilization of the micelles 263 µL of TMOS, the silica 
precursor, are added. The fluorescent dye is added as a solid 
directly inside the vial (Rhodamine B triethoxy silane derivative) after 
15 minutes and the solution is left under stirring for 45 minutes. The 
final step is the purification of 500 µl of nanoparticles solution by size 
exclusion chromatography with Sephadex G-25®. The synthesis of 
the control nanoparticles is made with the same steps but without 
adding the drug. The amount of drug entrapped is monitored 
recording the absorbance of Sorafenib at 268 nm where this 
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molecule shows an extinction coefficient of 28500 cm-1 M-1. The 
same strategy is used for the computation of the Rhodamine as 
reported previously5. In the case of the SRF loaded NPs, the 
synthesis yields nanostructure with an average value of about 80-
100 drug molecules loaded per nanoparticle and a dye doping 
degree lower than 1 dye per nanoparticles. The same dye doping 
degree is recorded for the control nanoparticles. This is due to the 
hydrolysis reaction of the dye triethoxy derivative which is too slow 
for this reaction resulting very inefficient. However, as a preliminary 
formulation, these nanoparticles show a very good loading property; 
for this reason, they can be considered a good compromise (in terms 




4.4 SORAFENIB RELEASE and NANOPARTICLE STABILITY  
 
As already mentioned, the water solubility of Sorafenib is very low 
and precipitation occurs at very low concentration (10-5 M). Typically, 
when the molecules aggregate in solution the absorbance becomes 
decreases while scattering increases. When SRF is entrapped 
inside the nanoparticles, it shows an optical behavior very similar to 
the one solubilized in methanol. In this condition, the absorption 
spectrum is composed by a main band at 265 nm. The kinetics of 
the release is studied monitoring the decrease of absorbance at this 
wavelength. This method allows to monitor directly the release and 
can be more accurate than other assays, as dialysis or 
chromatography, where the process of separation can alter the 




Figure 14. Absorbance of Sorafenib loaded Nanoparticles during the drug 
release. 
 
The amount of drug released by diffusion from the silica core to the 
bulk of solution is obtained by the equation: 
 
 
The SRF entrapped in the nanoparticle diffuse spontaneously and it 
is released almost quantitatively in three days, a much larger time if 
compared with the micellar architecture where the drug is release in 
few hours at the same concentration (0.5 µM).     
 







Figure 15. Trends of Sorafenib release % of Sorafenib Loaded 
Nanoparticles (red line) Pluronic F-127 Micelles (black line) 
In order to verify the stability of the nanoparticles, DLS analysis is 
performed, following their hydrodynamic size during the drug 
release. The DLS distributions confirm, as expected, that the 
hydrodynamic size remains constant during the drug release at 
about 33 nm.  
 
 
Figure 16. Dynamic light scattering distribution of Sorafenib Loaded 
Nanoparticles during the release  
time (h)


















The profile of nanoparticle stability and the drug release features 
allows proceeding with biological investigation in order to check the 
in vitro effects of this nanocarrier on a tumor tissue.   
 
4.5 PRELIMINAR IN VITRO TESTS 
The biological investigations have been made in collaboration with 
Prof. Lucia Morbidelli of University of Siena. 
Sorafenib is able to inhibit the cell proliferation and the tumor 
vascularization through inhibition of receptor tyrosine kinases 
(RTKs) inducing autophagy of the cells.  
The main disadvantages related to the use of this drug are due to its 
short half-life (24-48h)12 and toxicity13. Looking the mechanism of 
action of Sorafenib and its disadvantages, a SRF loaded 
nanostructure which can be entrapped inside a metastasis and is 
able to manage the drug release, can block the proliferation of the 
cancer cells and can inhibit in a more efficient way, respect to the 
free drug, the vascularization of the tumor mass, permitting to 
decrease the amount of drug used in the treatment and thus the side 
effects.  
In order to prove the effects of this nanoarchitecture on the growth 
of metastasis the in vitro tests are focused to investigate the 
proliferation and migration of a model cell (HUVEC, Human umbilical 
vein endothelial cells. They are typically used as a laboratory model 
system for the study of the function and pathology of endothelial 
cells (e.g., angiogenesis). These assays are able to highlight the 
differences about the effect of free molecules SRF and SRF Silica 
nanoparticles on the control of the growth and the organization of 
HUVEC cells over time (24-48h). Sorafenib shows an EC50 at 
concentration 5µM. The in vitro tests reported below are carried out 
setting the same concentration (5 µM) of drug for SRF and SRF-
NPs. The control NPs are at the same concentration of the 





4.6.1 Proliferation of endothelial HUVEC cells 
The experiment is performed in medium containing 1 and 5 % of 
serum as growth factor. The number of cells is counted after 24 and 
48 h of incubation. Firstly, the results show that cell proliferation in 
presence of NPs+Sorafenib is milder than the one observed with 
Sorafenib alone for both the serum concentration. This probably 
could be due to the slow release of the drug also in complex media. 
The nanoparticles without drug didn’t affect the cell viability meaning 
that these nanostructures, as already previously observed,6 exhibits 
a good biocompatibility.    
 
Figure 17. HUVEC cells viability over 24h and 48h after the 
incubation with SRF, SRF+NPs and NPs with different percentage 
of serum as growth factor 
 
4.6.2 Morphology of HUVEC after 24 h 
The results about the slow release of NPs+Sorafenib obtained by 
the proliferation assay are confirmed by looking the morphology of 
the cells after 24h from the incubation with the nanoparticle and the 
drug. Moreover, the cell morphology (and number) is altered in the 
presence of Sorafenib and NPs-Sorafenib: cells are elongated and 




Figure 18. Morphology of HUVEC cells exposed with NPS, 
NPS+SRF, SRF, and control for 48h with 1% of serum as growth 
factor 
 
4.6.3 Migration by scratch assay 
The migration by scratch assay allows to measure cell migration in 
vitro. The basic steps involve creating a ‘‘scratch’’ in a cell 
monolayer, capturing the images close to the scratch, and 
comparing the images to quantify the migration rate of the cells. This 
analysis is suitable for studies on the effects of cell–matrix and cell–
cell interactions, because it can mimic cell migration in vivo as 
wound-healing behavior.  For this reason, the migration by scratch 
assay is commonly used for the evaluation of angiogenetic control 
of endothelial cells. In this case, it is useful to highlight the effect of 
sorafenib and sorafenib nanoparticles in growing tissues processes. 
In this assay, empirically, confluent cells are scratched with a tip and 
then treated with nanoparticles and drug in presence of different 
amount of serum. After 18 h the area not covered by the cells is 




Figure 19. Migration scratch assay wound area of control, NPs, 
NPS+SRF and SRF incubated with 1% and 5% of serum as growth 
factor 
For the NPs control a complete healing of the wound is observed, 
again confirming the biocompatibility of this nanoplatform. On the 
contrary, for Sorafenib and NPs+Sorafenib a large wound area is 
measured, highlighting that the NPs+Sorafenib can affect cell 
migration in a similar manner as the SRF alone. For these reasons 
the SRF loaded nanoparticles can be consider as a potential drug 
delivery system able to control the growth of cancer tissue.     
 
4.6.4 Improvement for the In vivo Test  
The aims of this study are the design of a theranostic nanostructure 
based on Sorafenib loaded Pluronic F-127 Silica nanoparticles. A 
theranostic platform should provide a diagnostic tool (optical 
imaging) and at the same time a therapeutic agent. In this case, the 
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three-days drug release showed by the nanoparticle is particularly 
suitable for an in vivo evaluation because it could match well with 
the kinetics of tumor entrapment by EPR and body-clearance (within 
7 days) of the nanoparticles. However, the fluorescence features 
have to be improved increasing the dye doping degree for having an 
even higher sensitivity. Furthermore, the synthesis of this 
nanocarrier must be carried out immediately before the treatment 
because the drug is released spontaneously from the nanoparticle.  
To overcome these two problems, we modified the synthesis 
following these strategies: 
i) we derivatized the Rhodamine B with trimethoxy silane 
derivative, because of its faster hydrolysis, in order to 
increase the efficiency of the dye functionalization.  In this 
way, we were able to include 4 Rhodamine B dyes per 
nanoparticle, a doping degree that is higher than the FDA 
approved Cornell Dots;18  
ii) we formulated by lyophilization a stable “ready to use” 
water dispersible solid powder keeping a similar drug 




Figure 20. Absorbance of lyophilized SRF PluSNPs (2*10-7 M) 
monitored for 12 hours. 
These nanoparticles have showed promising preliminarily in vitro 
results. In particular, the extracellular signal-regulated kinase (ERK) 
is inhibited by Sorafenib only in presence of vascular endothelial 
growth factor (VEGF). Monitoring the expression of ERK HUVEC for 
the cells treated with VEGF is possible to evaluate the activity of the 
nanostructured drug carrier compared with the clinical drug.  
Wavelength (nm)









45 SRF molecules per NPs




Figure 21. ERK expressed by HUVEC in presence and in absence 
of VEGFP. The cells have been incubated with SRF, NPs+SRF and 
NPs.  
The expression of ERK in presence of VEGFP has revealed for the 
NPs+SRF platform a similar effect in all the concentrations tested 
(Figure 9). This result showed with this assay could promote the 




Here I reported the design of core/shell Pluronic Silica Nanoparticles 
specifically as promising nanoplatforms for drug delivery purposes. 
I engineered the synthesis of these nanoparticles in order to obtain 
a core entrapment of Sorafenib Tosylate - a lipophilic chemotherapy 
drug - which is used in clinical practice for malign renal and liver 
carcinoma treatment.  
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The drug release has been monitored looking at the decrease over 
three days of the absorption band of the drug localized about 260 
nm. The nanoparticles are stable during the drug release, as 
confirmed by Dynamic Light Scattering analysis. The Sorafenib 
loaded Pluronic Silica Nanoparticles formulation has been then 
evaluated in vitro in different assays aimed to prove the slow release 
of the drug in biological environment and the effect of this drug 
delivery system as anti-angiogenic platform. The results obtained 
have been encouraging for extending the research to in vivo 
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A very reliable and promising dye doped core/shell silica 
nanostructure, called PluSNP, was recently proposed by Prodi et. al 
as a bright luminescent nanoarchitecture suitable for bio imaging 
and drug delivery, with negligible in vivo and in vitro toxicity. 
PluSNPs are made of a silica core and biocompatible shell 
composed of Pluronic F-127, a PEGylated block co-polymer (Fig. 1). 
The PluSNP structure shows interesting features as a luminescent 
carrier for bio-sensing and as cellular marker1,2,3. To develop and 
enhance the uptake properties of this kind of nanoparticles, colloidal 
self-assembly can be a very interesting and suitable strategy, 
yielding functional and dynamic nanoarchitectures. 
 
Figure 22. Illustration of DEAC doped Pluronic Silica Nanoparticles 
with a positive charged shell  
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Nanoparticle size, surface charge and composition are known to 
affect the uptake of nanoparticles by cells. Considering this, 
nanoparticle surface can be covered with biocompatible polymers, 
proteins, polysaccharides which are able to manage the cellular 
membrane trafficking4,5,6. One of the most investigated structure 
able to control the nanoparticle surface and uptake properties is 
Hyaluronic acid (Hya, Fig. 2), a natural glycosaminoglycan widely 
distributed in the human body7. 
 
 
Figure 23. Illustration of hyaluronic acid: SHya 200 KDa and LHya 
1200 KDa. Schematic representation of the reaction of RB 
isothiocyanate and Hya hydroxyl groups.  
In physiological conditions Hya is negatively charged because of the 
deprotonation of the carboxylic groups that compose the structure 
of this polysaccharide. In addition, the polymer can interact with 
many water molecules via multiple hydrogen bonding: as a result, 
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hyaluronic acid is generally soluble in aqueous media. The 
biological, physical and chemical properties of this natural polymer 
can change drastically as a function of the molecular weight.8 
This study is focused on the interaction of with PluSNPs with 
hyaluronic acid, labeled with fluorescent dyes, of two different 
molecular weight (200 and 1200 KDa). 
Characterization of the interaction at the nanoscale has been carried 
out using: i) Forster Resonance Energy Transfer (FRET, that occurs 
in a nanoscale range, typically 1-10 nm) between dye doped 
PluSNPs (doped with a donor dye) and Rhodamine b labeled Hya 
(acting as acceptor in the FRET couple) and ii) the conformation-
sensitive properties of the fluorescent hyaluronic acid, whose 
photophysical properties undergo significant changes when 
structural reorganization processes occur. 
 
5.2 PROBING CONFORMATIONAL CHANGES OF 
HYALURONIC ACID  
The Hya-Rhodamine B (Hya-RB) bioconjugate shows unique optical 
properties that depend on the folding conformation of the polymer 
chain. We exploited this behavior to probe the changes in the 
arrangements and reorganization of the hyaluronic acid when 
interacting with the environment and with other nano-objects. RB is 
a widely-used fluorophore for many applications, from bioimaging to 
lasing. This fluorophore, when well dispersed in a dilute condition 
displays remarkable optical properties such as very high brightness 
(extinction coefficient close to 100000 cm-1 M-1 and fluorescence 
quantum yields reaching 0.7 in ethanol) and a strong photo-stability. 
Moreover, the absorption and the emission spectra are localized in 
a spectral region suitable for bioimaging where phenomena of auto-
bioluminescence are typically negligible. As other fluorescent 
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molecules, the optical properties are sensitive to the confinement 
when the local concentration of the dye is very high. Specifically, 
aggregation induces a decrease of the molar absorption coefficient 
of the band localized at 560 nm and strong quenching of the band.9 
The chemical functionalization of hyaluronic acid with this 
fluorophore allows the investigation of the changes in the folding and 
polymer arrangements by monitoring the spectral properties of RB. 
The disaggregation of the polymer, increasing the distance among 
the dyes, promotes an increase of the brightness, because 
absorption spectra increase as well as fluorescence quantum yield.  
The effect of addition of PluSNPs on the photophysical properties of 
Hya-RB is shown in figure 3. The absorption band of RB is slightly 
red shifted and the shoulder at 530 nm drastically decreases 
compared to the absorption peak (Figure 3A). In addition, the NP-
Hya interaction induces an increase of the photoluminescence 
quantum yield (Figure 3B) of the RB by 250%.  
 
Figure 3. Spectral properties of Hyaluronic acid 0.5 µM in PBS pH 
7.4. A) absorption spectra of PluSNP+SHya (black line) and SHya 
(red line). B) Relative Fluorescence Quantum yield of: 




Given these peculiar photophysical changes, the unfolding process 
can be monitored via the following spectral parameters: 
1. The value of the absorbance ratio at wavelengths (about 560 
nm) Amax /A530 nm, which provides an averaged information 
on the aggregation status of all rhodamine dyes in solution: 
the higher the Amax /A530 ratio, the lower the aggregation of 
rhodamine dyes.  
2. The value of the differential absorbance (Ai/Ai-1 with i 
Hyaluronic acid concentration) ratio at wavelengths Amax 
/A530 nm, which allows to focus on the last portion of 
hyaluronic acid added, or on its effect on the polymer already 
present in solution during the titration.  
3. The increase of emission intensity at 580 nm, which is related 
to the decrease of rhodamine-self quenching. 
Even though the effect of PluSNPs on the conformation of Hya-RB 
is clearly put in evidence, it is still unclear whether the “unfolded” 
Hya-RB remains in close contact with PluSNPs, or if it diffuses freely 
in solution, in the unfolded conformation, without further interacting 
with PluSNPs. 
Thus, to probe not only the effect of the interaction between 
PluSNPs and Hya-RB, but also the persistence of the interaction 
and the distance at which it takes place, we designed a FRET couple 
between dyes embedded in the PluSNPs (diethylamino coumarin 
DEAC, donor dye) and dyes covalently linked to the polymer (RB, 
acceptor dyes). The large Forster Radius (3.83 nm), due do the high 
PLQY and ε of donor and acceptor, respectively, and to the good 
spectral overlap, allows to monitor the interactions between 
PluSNPs and Hya-RB, within 10 nm distance. It is indeed very 
important to note that energy transfer can occur only when donor 
and acceptor are very close (within roughly 2R0 distance). Bringing 
the spectral information of the RB status and its sensitization 
coupled to the quenching of DEAC due to energy transfer, the 
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polymer/nanoparticles interaction can be evaluated with nanoscale 
resolution. 
FRET characterization is carried out by monitoring the fluorescence 
spectra obtained at two excitation wavelengths: 
1) λexc = 400 nm, where the absorption of DEAC is dominant, to 
check the quenching of the donor and the sensitized emission 
of the acceptor 
2) λexc = 530 nm, where only the rhodamine dye absorbs, to 
check the emission of the acceptor, when directly excited.  
Experimentally, the interaction between SHya-RB (molecular weight 
200 KDa) and DEAC-PluSNPs is evaluated recording the 
absorbance and emission spectra of a 0.2 µM solution of PluSNPs 
in PBS pH 7.4 and upon an addition of increasing amounts of the 
polymer solution. In addition, a control experiment is made starting 
from a solution without NPs to evaluate the dependence of SHya-
RB conformation on its concentration. As shown before, the 
absorption spectra highlight notable differences in terms of 
absorption ratio at max/530 nm. For all the tested concentrations, 
the Amax /A530 ratio (Figure 4, C) shows the higher values in 
presence of PluSNPs.     
 
Figure 4. Absorption spectra of A) titration of PluSNPs 0.2*10-6 M 
with SHya (up to 5 eq.). B) Hya from 0 to 1*10-6 M. C) Absorbance 
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ratio trends of RB A max/530 nm of PluSNPs and SHya (black) and 
SHya (red). [PluSNP]/[SHya]=1 green line 
In order to check how each addition of hyaluronic acid affects the 
status of the rhodamine already present in solution, we computed 
the differential absorbance. This parameter allows to verify if the 
succeeding hyaluronic acid is able to modify the conformation of the 
polymer already in the system (in interaction with the nanomaterial 
and in the bulk of solution). As well as the absorption, the differential 
absorption ratio trends (Figure 5) indicate some differences when 
SHya interact with PluSNP respect the SHya alone. The decreasing 
trend of the absorbance ratio on the differential spectra of the SHya 
and nanoparticles system indicates that for each addition of 
hyaluronic acid a modification of the aggregation state of rhodamine 
occurs.  
 
Figure 5. Differential Absorbance of: A) titration of PluSNPs 0.2*10-
6 M with SHya (up to 5 eq.). B) Hya from 0 to 1 10-6 M. C) Differential 
Absorbance ratio trends of RB A max/530 nm of PluSNPs and SHya 
(black) and SHya (red), [PluSNP]/[SHya]=1 green dashed line 
The emission spectra confirm the information obtained by 
absorbance spectroscopy: Hya is interacting with PluSNPs at low 
concentrations, while at high concentrations it displays similar 
photophysical behaviours as in absence of PluSNPs. Indeed, RB 
displays high quantum yield associated with high Amax /A530 ratios, 
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and low quantum yield associated with low Amax /A530 ratios (figure 
6).  
 
Figure 6. Rhodamine B Relative Quantum Yield of 2*10-7M 
PluSNP+SHya (black line) and SHya (red line). [PluSNP]/[SHya]=1 
(green dashed line).  
 
 
5.3 MODEL OF INTERACTION Hya 200 KDa (SHya) and PluSNPs 
The trends of the absorbance ratio and of the quantum yield could 
be in agreement with two possible interaction mechanisms, based 
on either a “multilayer” or a “monolayer” process. In a multilayer 
process, many filaments can interact with a PluSNP forming several 
layers, where the additional layers not only have different properties, 
but can even change the properties of the first layer, while in a 
monolayer process the first layer passivates the surface which is 
thus not anymore available for interacting with other polymers, which 
thus remain in the bulk of the solution. 
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The information obtained by the absorbance spectra is not 
conclusive, since both models can justify the decrease of the 
peak/shoulder ratio observed in absorbance (figures 4 and 5). To 
select the most correct interaction model we carefully analyzed the 
information derived from the energy transfer between donor (DEAC 
dyes bound inside the core of the nanoparticle) and acceptor dyes 
(the RB linked to the polymer). Indeed, by combining the information 
gained exciting the donor (i.e., donor quenching and acceptor 
sensitized emission) and the information obtained by selectively 
exciting Hya-RB, it is possible to discriminate the amount and the 
properties of RB dyes in interaction with PluSNPs from the ones 
dispersed in the solution. Thus, we monitored the fluorescence 
properties of the sensitized RB (excited via DEAC with exc = 400 
nm) with those of directly excited RB dyes (exc = 530 nm, yielding 
an average information of all rhodamine dyes present in solution).  
The emission intensity trend of the RB (Figure 7) increase as 
function of SHya concentration and after an inflection point at 0,75-
1 polymer equivalents per nanoparticle seems to increase slightly, 
which is in line with the absorption trends. In presence of PluSNPs, 
the RB from the very first addition is more emissive then the system 
alone.  
 
Figure 7. A) Emission spectra of solutions obtained upon addition of 
increasing amounts of Hya up to 1x10-6 M to a buffered 2*10-7 M 
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solution of PluSNPs with SHya (black line) and to a buffered solution 
only (red line). B) Emission Intensity trends of RB at 580 nm of 
PluSNPs and SHya (black) and SHya (red), [PluSNP]/[SHya]=1 
(green dashed line). (λex=530 nm) 
 
For the description of the energy transfer process it is necessary to 
report the emission quenching of the donor (DEAC of PluSNPs) as 
a function of the concentration of the acceptor (Rhodamine B of 
Hya). The DEAC emission decrease for all the concentrations of Hya 
up to 80% of the initial intensity (Figure 8).  
 
Figure 8. A) emission spectra of the titration of DEAC PluSNPs with 
SHya B) Emission Intensity trend of DEAC emission at 470 nm. 
(λex=400 nm). [SHya]/[Hya]=1 (green line) 
The clear indication of the model that describes the interaction is 
found on the sensitization of the acceptor. In agreement with the 
theory, a FRET sensitization derives from the product of the 
quenching of the donor and the quantum yields of the acceptor. 
From a theoretical view point the two models should show different 
sensitized emission trends. In the case of multilayer interaction, all 
RB dyes (Q.Y. decreasing with [Hya]) are sensitized, and the 
resulted trend features a maximum point (Figure 9, A); if self-
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quenching occurs between the dyes of the different layers, a 
decrease of the luminescence is expected afterwards. In the case of 
monolayer interaction, sensitization involves only the dyes of the 
monolayer, that are the brightest because they are not self-
quenched (QY approx. constant). A plateau is expected afterwards, 
because the Hya in excess would be not interact with the NPs, and 
thus not involved in the energy transfer process (Figure 9, B). 
 
Figure 9. Schematic illustration of theoretical sensitized emission of 
A) Multilayer and B) Monolayer 
The sensitized emission (Figure 10A) yields the information of only 
those RB dyes that are in interaction with the PluSNPs. The 
experimental sensitized emission, as well as the computed 
sensitized emission (which thus represents the sensitized emission 
of all RB dye in solution, calculated as the product of the average 
Q.Y. and the quenching ratio, Figure 10B), both suggest that the 
most correct interaction model is the “multilayer” one. In conclusion, 
the interaction of SHya and PluSNPs can be modeled as a multilayer 
process where the nanoparticles are surrounded by numerous 
layers of polymer, where the absorption of each layer induces 
reorganization and photophysical changes in the bottom layers. The 





Figure 10. A) RB sensitized emission (green line) computed by the 
product of the DEAC quenching ratio computed as 1 − 𝐼 𝐼0⁄ (black 
line) and the SHya fluorescence quantum yield (red line). B) 
Comparison between the computed RB sensitized emission (green 
line) and the experimental one (blue line). [SHya]/[PluSNP]=1 (red 
dashed line).  
 
5.4 HYALURONIC ACID 200 KDA (SHya) – MEDIA EFFECT 
The multilayer model can describe the interaction between Hya and 
NPs in PBS at pH 7.4 a very high ionic strength condition, a pH at 
which the poly-anion can be considered fully deprotonated. As other 
polyelectrolytes, Hya can change its conformation as a function of 
the dispersion media. In order to verify the effects of different 
aqueous media on the polymer conformation, the same experiment 
has been carried out in deionized water, phosphate buffer saline pH 
5.5 and phosphate buffer 7.4. The analysis of the absorbance ratios 
(Figure 11) shows that in all the media tested the fluorescence trend 
is different, confirming that the ionic strength and the pH play an 




Figure 11. Absorbance ratio 560 /530 nm of SHya and PluSNPs in 
different media: A) Deionized water, B) Phosphate Buffer pH 7.4, C) 
Phosphate Buffer Saline pH 7.4 and D) Phosphate Buffer Saline pH 
5.5.  
The trends (Figure 12) of quenching ratio of DEAC and the RB 
relative quantum yields, and the computed and experimental 
sensitized emissions, highlight that the interaction in all the media 
tested can be described by a multilayer model. 
 
 
Figure 12. Emission, quenching and computed/sperimental 
sensitization of PluSNP+SHya in different media A) deionized water, 
B) Phosphate buffer pH 7.4, C) Phosphate buffer saline pH 7.4 and 





5.5 Hyaluronic acid 1200 KDa (LHya) 
The polymer properties in general can change drastically with the 
molecular weight. Moreover, in recent biological investigations, 
length of the Hya chain is indicated as a key factor that can influence 
the pathological regulation of a metastasis7. For these reasons is 
necessary to expand the characterization of the interaction between 
PluSNP and Hya to another molecular weight. We have 
functionalized a 1200 KDa Hya (LHya) as SHya obtaining a similar 
dye doping degree. Firstly, that polymer has been investigated in 
PBS pH 7.4 and water, to observe on the LHya the media effect 
(Figure 13). Also in this case the two trends were different, 
suggesting, as expected, that also for this heavier polymer the 
media can change the reorganization.  
 
Figure 13. A) Absorption spectrum of LHya in PBS increasing the 
concentration. B) Absorption ratio 560/530 nm of LHya in water and 
PBS pH 7.4 
Like SHya, LHya presents differences on the trend of absorbance 
ratio in presence of PluSNP. Also in this case, PluSNP increase the 
value of the absorbance ratio, indicating that interaction provokes 
changes on the polymer reorganization. The trend has an inflection 
point at about 2-3 PluSNPs per filament (Figure 14) while the trend 
of SHya, described previously, is centered at about 1 PluSNP per 




Figure 14. A) Absorbance LHya+PluSNP 0.1*0-7 M (black), B) and 
LHya (red) and C) absorbance ratio in PBS pH 7.4. 
[PluSNP]/[LHya]=2.0 (green dashed line) 
As in the case of the lighter polymer, we performed experiments to 
quantify the efficiency of the energy transfer between NPs and LHya 
in PBS pH 7.4. Fixing the concentration of the NPs (0,1 µM) and by 
several additions of LHya, the emission properties of the donor and 
the acceptor have been recorded. The trends of the quenching of 
the DEAC and of the sensitized emission signals confirm that the 
interaction of the LHya and PluSNPs occurs with a different ratio 
respect to the one observed SHya: again the inflection point has 
been observed at 2-3 PluSNPs per filament.  
 
Figure 15. A) Emission Spectra of DEAC of PluSNP 1*10-7 M in 
presence of different amount of LHya (up to 5 eq.) B) Emission trend 
of DEAC at 455 nm (black line) and of RB at 580 nm (red line). 
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[PluSNPs]/[LHya]=1 (green dashed line), [PluSNPs]/[LHya]=2 (blue 
dashed line) (λex=400 nm). 
This conclusion is confirmed by the direct excitation of RB which is 
in line with the sensitized emission.  
 
 
Figure 16. A) Emission Spectra of RB in different amount of LHya in 
presence of PluSNP 1*10-7 M. B) B) Emission trend of RB at 580 
nm. [PluSNPs]/[LHya]=1 (green dashed line), [PluSNPs]/[LHya]=2 
(blue dashed line) (λex=530 nm). 
5.6 Interaction Mechanism comparison of LHya and SHya.   
To highlight differences on these interactions between PluSNPs and 
Hya (SHya and LHya), a titration fixing the concentration, in term of 
monomer units, of hyaluronic acid and adding several amounts of 
nanoparticles has been carried out. In particular, the concentration 
of the polymer was 100 µM for SHya and 16,6 for µM LHya. RB 
absorbance ratio (Figure 17, E) shows an increase after each 
addition of the solution of PluSNPs. The absorbance ratio trends for 
these different polymers give an indication about the ratio of the 
interaction which provoke a drastic change on the polymer 
reorganization. The inflection points are localized at 6 PluSNPs per 





Figure 17.  A) Absorption spectra of the titration of SHya and B) 
LHya with increasing amounts of PluSNPs in PBS pH 7.4. C-D) 
Detail of RB absorption spectra of the titration of SHya and LHya, 
respectively. E) Trend of the absorption ratio 560 nm/530 nm SHya 
(black dots) LHya (white dots).  
 The emission properties of the system, as the quenching ratio (1 −
𝐼 𝐼0⁄ , I= emission intensity of donor in presence of acceptor, 
I0=emission of the donor in absence of the acceptor) and the 
sensitized emission, can confirm the same ratios where the polymer 




Figure 18. A-B) Emission spectra of SHya and LHya, respectively, 
upon addition of PluSNPs (exc = 400 nm). C) the quenching ratio 




Figure 19. Sensitized emission and normalized sensitized emission 
The direct excitation of the RB confirms, for the two polymers, the 
same results in terms of differences of PluSNPs/Hya ratios (Figure 
20). In general, the interaction is driven by the ratio NP/Hya 
monomers concentrations meaning that LHya is able to interact with 
more nanoparticles then SHya. The results obtained suggest that a 
single chain of LHya is able, as expected, to wrap a higher number 
of NPs respect to SHya.   
 
Figure 20. A) Spectra of the RB emission enhancement due to the 
PluSNP additions B-C) Trends of the emission intensity and the 
normalized emission of the titration for SHya (black dot) and LHya 
(white dot).   (λex=530 nm). 
It is interesting to underline that the normalized trends are all very 





5.7 HYDRODYNAMIC SIZE DISTRIBUTION   
To confirm the size difference of the PluSNPs and SHya/LHya 
aggregates the investigation of the hydrodynamic diameter 
measured by Dynamic Light scattering has been carried out. The 
dynamic light scattering (DLS) is a technique that can be used to 
determine the hydrodynamic diameter and its distribution of particles 
dispersed in a fluid. 
 In this system the analysis indicates which is the behavior of the 
hydrodynamic size of the hyaluronic acid and averagely the 
dimension of the aggregates in presence of nanoparticles. In 
general, the hydrodynamic diameter of Hya alone is very large and 
Hya in solution should compose very big aggregates. Averagely 
DLS reveals that (Figure 21) the aggregates between PluSNP and 
Hya are bigger than nanoparticle alone but smaller than the 
aggregates formed by Hya alone.  
In general, DLS analysis cannot provide information about the 
behavior of the single component in solution; while additional 
information on the dynamic of Hya can be obtained using 
fluorescence correlation spectroscopy (FCS). This technique 
permits the selective observation of the diffusion of a fluorophore by 




Figure 21. Hydrodynamic diameter of PluSNP 1*10-7 M with different 
concentration SHya (red empty triangle) and LHya (Blu empty 
square) and SHya (red filled triangle), LHya (blue filled square) 
alone. (PBS pH 7.4). 
 
5.8 Fluorescence Correlation Spectroscopy on Hya/PluSNPs 
ensemble 
Fluorescence correlation spectroscopy (FCS) is an experimental 
technique using statistical analysis of the fluctuations of 
fluorescence in a system in order to observe dynamic molecular 
events, such as diffusion or conformational fluctuations of 
biomolecules.  The diffusion of an object in solution is related to its 
hydrodynamic size. The FCS is a very powerful tool because permit 
the selective excitation of the dye of interest. In this case, it was 
possible to highlight the faith of the RB bound to the polymer and 
following with very high resolution what happened to the polymer 
when interacting with the nanoparticles (at very low concentration as 
well). Averagely, the Hyaluronic acid in solution forms very big 
aggregates (Fig 22).  In particular, LHya forms bigger objects than 
SHya. The addition of PluSNPs brakes the matrix formed by the 
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polymer aggregates composing of ensembles which diffuse slower 
than the PluSNPs alone. SHya aggregates show a diffusion very 
similar to the nanoparticles alone and in interaction at low 
concentration.  However, the breaking effect of the Hya matrix 
provoked by the nanoparticles is visible at the highest concentration 
(Figure 22, B). The FCS results are useful to imagine what 
happened during this interaction: the polymer composes aggregates 
where the rhodamine dyes are quenched, then the nanoparticle 
disrupts the aggregates provoking a decrease of the rhodamine self-
quenching and a decrease of the size.     
 
Figure 22. Plot of the correlation of Hya and PluSNPs and 
PluSNP+SHya at three different concentration respectively 1, 10, 
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100 nM of A) LHya and B) SHya. C) schematic representation of the 
Hya aggregates disruption provoked by the PluSNPs.    
 
5.9 PRELIMINAR IN VITRO TEST 
To investigate the effect of hyaluronic acid on the cellular uptake of 
PluSNPs, a preliminary in vitro test has been carried out using HeLa 
cells as a tumor cell line model. Moreover, the characterization has 
been carried out with a confocal microscope checking the emission 
intensity of Rhodamine B modified Pluronic silica nanoparticles (very 
bright). In this case we used a not labeled hyaluronic acid assuming 
that it could have the same effect on the cell interaction as the 
fluorescent one. The experiments are made incubating the cells for 
3 hours with PluSNPs 1*10-7 M and SHya 1*10-7 M or LHya 1.6*10-
8 M ([PluSNP]/[SHya]=1, or ([PluSNP]/[LHya]=6) to observe if there 
were a different nanoparticle internalization upon changing the size 
of the polymer.  As it can be observed in figure 23, the intensity ratio 
of the aggregates of PluSNP and Hya are internalized more 
efficiently than the nanoparticles alone. Moreover, the 
nanoarchitecture composed by LHya and nanoparticles shows the 
best uptake level (100% more than PluSNPs). This increase in the 
internalization kinetic, if confirmed also with other cell lines and in in 
vivo experiments, could suggest an interesting strategy to increase 




Figure 23. A) BOX plot of Intensity inside/outside the cell ratio of 
PluSNP 1*10-7 M (red box), PluSNP+SHya ([PluSNP]/[SHya]=1) 
(green box) and PluSNP+LHya ([PluSNP]/[LHya]=6) (blue box). B) 
example of HeLa cell incubated with PluSNPs. 
 
5.10 CONCLUSION 
Here I reported an extensive investigation of the interaction between 
core shell nanoparticles PluSNPs and a biocompatible 
polysaccharide, namely RB-derivatized Hyaluronic acid (Hya). This 
fluorescent biopolymer reveals a very promising property, since the 
changes of Hya conformation can be monitored following both the 
absorption and in emission spectra of RB. The information obtained 
by the changes in the photophysical properties of RB can also be 
suitably combined with the information obtained evaluating the 
energy transfer efficiencies between donor dyes embedded in 
PluSNPs (DEAC) and RB-Hya as acceptor. The FRET 
investigations allow the understanding at the nanoscale of the 
mechanism of interaction, indicating that a nanoparticle is 
surrounded by many Hya filaments yielding a multilayer structure. 
The effect of the molecular weight of Hya on the assembly has also 
been investigated. In this context, energy transfer is useful to 
determine the steps of this interaction. We observed similar 
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photophysical properties for RB when SHya interacts with 1 PluSNP, 
or when LHya (6 times longer polymer) interacts with 6 PluSNPs.  
The hydrodynamic radius of Hya in bulk solution and in interaction 
with PluS NPs are evaluated with two different correlation 
techniques, namely DLS and FCS. The two techniques allow to 
confirm the hypothesis made evaluating the photophysical data, 
highlighting moreover the aggregated nature of Hya in solution 
which is disrupted in presence of the nanoparticles.  
Finally, the different aggregates are evaluated in cellular tests where 
HeLa cells are incubated with PluSNP and SHya (1:1) and LHya 
(6:1) fixing the concentration of nanoparticle at 1*10-7 M. The 
biological assay indicates that PluSNPs uptake is largely enhanced 
in presence of LHya, a very interesting and promising result for 
increasing the theranostic abilities of the PluSNPs.  
 
 
5.11 TECHNICAL NOTES 
 
MATERIALS AND METHODS 
Following compounds are purchased by Sigma: Rhodamine B 
isothiocyanate mixed isomers (98%), 7-(Diethylamino) coumarin-3-
carboxylic acid (98%, DEAC), Rhodamine B mixed isomers (98%, 
RB), Pluronic F127, Sodium Chloride (98%), glacial acetic acid (…), 
dialysis membrane 12 MWCO, N,N’- disuccinimidyl carbonate 
(94%), 4-(Dimethylamino)pyridine (DMAP, 99%). (3-
Aminopropyl)triethoxysilane (99%, APTES), Tetraethyl Orthosilicate 
(98%, TEOS), 1,6Diaminohexane (98%), chlorotrimethylsilane 
(98%, TMSCL) Solvents used: dry tetrahydrofuran (dry, THF), 
acetone (technical grade), MilliQ water (18.2 µS), Dichloromethane 
(technical grade). Phosphate buffer saline pH 7.4 and the other 
buffer are made dissolving the opportune amount of monohydrogen 
disodium phosphate and sodium phosphate setting the right pH with 
small amount of NaOH/HCl with a pH-meter. For the ionic strength 
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control are used sodium chloride (NaCl) and potassium chloride 
(KCl).  
 
RHODAMINE B LABEBELED HYALURONIC ACID SYNTHESIS 
Hyaluronic acid (200 KDa SHya and 1200 KDa LHya) is labeled with 
Rhodamine B isocyanate fixing the monomer/fluorophore molar ratio 
of 7 equivalents. A 50 mg di solid hyaluronic acid (200, 1200 KDa) 
are dispersed in 12 ml DMSO and the right amount of Rhodamine B 
dye (3 mg for 200 KDa and 18 mg for 1200 KDa) are dissolved and 
the reaction is carried out overnight. After that the reaction is diluted 
with 24 ml of d.i. water and the solutions are dialyzed against water 
(cut off membrane 12 MWCO) until the water is resulted colorless. 
the doping degree is checked by a UVvis spectroscopy and is the 
same for both polymer lengths about 1 fluorophore every 50 
monomers. The average fluorescence quantum yield range for the 
SHya from 2.5*10-3 to 2.5*10-2 and for LHya 2.7*10-3 to 0.11. the 
quantum yields are measured using the Rhodamine B in ethanol as 
a reference with Q.Y.=0.96. 
TRIETHOXYSILANE DERIVATIVE OF COUMARIN-DEAC  
 
 








TRIETHOXYSILANE DERIVATIVE RHODAMINE B SYNTHESIS 
 
Figure 25. rhodamine B triethoxysilane derivative 
The rhodamine B derivative has been synthesized using reported 
procedures11. 
 
AMINO DERIVATIZED PLURONIC F-127 SYNTHESIS  
 
 
Figure 26. Schematization of the synthesis of F127-amino 
Pluronic F127 N-disuccinimydil carbonate F127-carbonate is 
synthesized adapting reported procedures12. A toluene solution of 
Pluronic F127 (4.01 g, 0.32 mmol, 1.0 eq, 100 mL) is distilled under 
reduced pressure at 50-60°C in a 250 mL round bottom flask. The 
residue is dried under vacuum and finally solubilized with 15 mL of 
dry THF. N,N’- disuccinimidyl carbonate (2) (0.80 g, 3.1 mmol), 
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solubilized in 7.0 mL of acetone is added. DMAP (0.41 g, 3.32 mmol) 
was then slowly added at room temperature under stirring by a 
dropping funnel. After 12 hours, F127-carbonate is precipitated with 
Et2O and recovered by centrifugation (25 minutes, 5000 rpm). The 
precipitate is resuspended and centrifugated several times with 
acetone (20 mL), until no trace of the excess reagent (TLC, 
chloroform-methanol 5:1) is present. The product is finally dried 
under vacuum and directly used for amine functionalization.  
 Pluronic F127-di-yl bis ((6-aminoesyl)carbamate) F127-amino 
is synthesized adapting reported procedures13. In a flamed 100 mL 
round bottom flask dried under vacuum, 1,6Diaminohexane (3) 
(1.908 g, 16.4 mmol) is solubilized with 10 mL of dry DCM. A 10 mL 
DCM solution of (F127-carbonate) (2.0 g, 0.16 mmol) is then slowly 
added under stirring at room temperature. After 3 hours the reaction 
mixture is distilled under reduced pressure and the residue is 
solubilized with 20 mL of water. The resulting solution is dialyzed vs. 
Milli-Q water (regenerated cellulose, 12 KDa) for about 20 h under 
gentle stirring. The dialyzed solution is evaporated under reduced 
pressure and finally dried under vacuum, obtaining 0.84 g of white 
solid (yield 42%).  
• 1H-NMR (300 MHz, CDCl3, 25°C): δ = 8.21 (2H, s, -NHCO-), 
5.09 (4H, s, -NH2), 4.14 (4H, s, -CH2OCO-), 3.76-3.75 (4H, 
m, -CH2CH2OH), 3.58 (s, -OCH2CH2O-) +  3.51-3.42 (m, -
OCH2CCH3) + 3.33 (m, -OCH2CHCH3) ~1000H, 3.09 (4H, s, 
CH2NH2), 1.45 (8H, s, -NHCH2CH2CH2CH2CH2CH2NH2), 
1.25−1.24 (8H, s, NHCH2CH2CH2CH2CH2CH2NH2), 1.08 (s, -
OCH2CHCH3) ~195H;  
•  13C-NMR (100 MHz, CDCl3, 25°C): δ = 75.7, 75.6, 75.4, 75.3, 
73.6, 73.5, 72.2-73.0 (m), 70.0, 17.7, 17.5.  




In a typical preparation of core−shell silica-PEG (poly(ethylene 
glycol)) nanoparticles, 100 mg of Pluronic F127 (70 mg Pluronic 127 
and 30 mg amino modified Pluronic f-127) and the desired amount 
of the silanized dyes (about 0.7 mg) are carefully solubilized with 
1.0−2.0 mL of dichloromethane in a 20 mL glass scintillation vial. 
The solvent is evaporated from the homogeneous solution by means 
of a gentle nitrogen flow and subsequently under vacuum at room 
temperature. NaCl (68.6 mg) is added to the solid residue, and the 
mixture is solubilized at 25 °C under magnetic stirring with 1565 μL 
of acetic acid 1 M. Tetraethyl orthosilicate (TEOS, 179 μL, 0.8 mmol) 
is then added to the resulting aqueous homogeneous solution 
followed by chlorotrimethylsilane (TMSCL, 10 μL, 0.08 mmol) after 
180 min. The mixture is kept under stirring for 48 h at 25 °C before 
dialysis treatments. The dialysis purification step is carried out 
versus water on a precise amount of nanoparticle solution (1500 μL) 
finally diluted to a total volume of 5 mL with water.  
  
SPECTROFLUOROMETRIC TITRATION 
The spectrofluorimetric titration is carried out recording the 
absorption spectra with a Perkin Elmer Lambda 45, and the 
emission spectra with Perkin Helmer Ls 55. of solutions with 
different ratio of nanoparticles and Hyaluronic acid (and Hyaluronic 
acid alone as a control). These spectra are recorded putting the 
sample on PMMA plastic cuvette for optical purposes. All the 
solutions are made from Hya (0.4 µM LHya and 5.1 µM SHya) and 
PluSNPs (20 µM) water stock solutions.  The solutions in cuvette are 
prepared in different media (d.i. water, Phosphate buffer Ph 7.4, 
PBS pH 7.4 and PBS pH 5.5). For the fluorescence investigation 
each sample is exited at 400 nm to observe the quenching of the 
dye bound to nanoparticles and sensitized emission of the RB and 
at 530 nm in order to observe the emission of the RB bound to the 
polymer. Each emission spectrum is corrected by FG factor and by 





The solutions of Nanoparticle and Hyaluronic acid are prepared in 
PBS pH 7.4 form the respective stock solution in a Semi-micro sized 
plastic cuvette. For each cuvette the DLS is measured averaging 
three runs where ten accumulations of 20 seconds are recorder for 
the correlation. The analysis is carried out with Zeta-sizer Nano form 
Malvern instrument with a laser excitation of 633 nm.  
 
FCS 
FCS is recorded using the correlator module of Zeiss LSM 880 
confocal microscope, exciting the nanoparticle with a laser at 405 
nm and the Hya at 564 nm. The measures are obtained averaging 
ten correlogram obtained recording the fluorescence fluctuations for 
20 seconds with a bin time of 10-6 – 10-4 seconds. The sample are 
tested on a coverslip posed on 40x water objective with an aperture 
number of 1.2. The sample are made dissolving the opportune 
dilution of nanoparticles (10 nM) with different amount of Hyaluronic 




The cell culture is provided by Prof. Stefania Rapino from University 
of Bologna. The HeLa cell are plated in a 35 mm petri optical dish 
with Dulbecco’s Modified Medium 12 hours before the incubation 
with nanoparticles and hyaluronic acids.   
 
Confocal Microscope 
The images of the cells incubated with Rhodamine B labeled 
PluSNPs and Hyaluronic acid has been obtained with Olympus FV 
3000 using a laser excitation of 514 nm and a water-immersion 40x 
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DEVELOPMENT AND APPLICATION OF A NOVEL 
FLUORESCENCE CROSSCORELATION IMAGING 
TECHNIQUE 
6.1 Overview 
In this chapter I reported the description of the results obtained 
during my six-months internship at “Laboratory of 
Fluorescence Dynamics – LFD”, “University of California”, 
under the supervision and mentorship of Enrico Gratton and 
Michelle Digman. The investigation has been focused on the 
application of a novel two-dimensional FCS techniques called 
2D pair correlation function (pCF(δr)). This novel technique is 
applied for the investigation of the dynamics of a fluorescent 
labelled protein (Ku-EGFP) inside the nucleus of living cells. 
Ku protein is involved on the repair mechanism of double 
strands break (DSB) damage of DNA, which is one of the most 
hazardous genomic illness. DSB repair occurs with a structural 
reorganization of the chromatin that can provoke a change on 
the motion of the proteins which populate the cellular nucleus. 
To investigate this kind of phenomena techniques, which can 
permit to obtain information with very high spatio-temporal 
resolution (100-1000 µm and 10-5 to 10-3 s) are required. 
Moreover, these informations should be achieved on two-
dimensional fashion because dynamic process can occur 
simultaneously in different cellular sectors. The innovative 
approach of 2D pCF is proposed as a promising tool to discover 
the physics behind biological phenomena giving information 
about the dynamics of the fluorescent object of interest. This 
very promising technique is in principle suitable for any 
fluorescent probe including dyes, nanostructures and 2D-pCF, 
that can be used for the description of processes involving 
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cellular uptake and localization of fluorescent theranostic 
materials. 
 
6.2 pCF(δr)  
The 2D-pCF approach was developed from the results showed 
in a paper written by Michelle Digman and Enrico Gratton in 
2009 called “Imaging Barriers to Diffusion by Pair Correlation 
Functions”. The basic idea behind the pair correlation method 
is to statistically follow the same particle during its diffusion. In 
this work they followed a fluorescently labeled molecule in the 
membrane. The fluorescence intensity fluctuation was rapidly 
sampled at each point in the 2D plane (grid in Figure. 1). Only 
the same molecule will produce an average cross correlation 
with a given time delay at two different points in the grid. A 
positive correlation will occur if the fluctuation of the intensity of 
a molecule at position 2 interferes with the fluctuation of the 
intensity at position 1, i.e., only if the same molecule is moving 
there with a given time delay. If a barrier to diffusion (indicated 
by the blue line in figure 1) is present, there will be a lag of 
correlation between position 3 and 4. If the molecule hits an 
obstacle that is penetrable (but with a certain retention time 
inside the obstacle) or it diffuses around the obstacle, a 
delayed correlation compared to the free diffusion will be 




Figure 24. Schematic representation of the spatial pair-correlation 
method1. 
The used pair correlation function (pCF) is defined as follows:  
 
where δr is the distance between the two points and τ is the 
delay time, F(t, δr) is the fluorescence intensity at the time t and 
the distance δr from the origin. For each pixel of the image the 
pCF is calculated for all the adjacent neighbour pixels in a circle 
around the pixel of interest at a given pCF distance δr. For each 
direction, a pCF function with a maximum is obtained at a 
certain delay time if the correlation is positive, while no 
maximum is obtained if no correlation can be found. The 
maximum position is proportional to the average time that a 
molecules takes to travel a certain distance. From the 
delaytimes of the maxima in each direction is derived a 





Figure 25. a) Laser scansion frames acquisition sample. b) 
Representation of the stellate pCF. c) Correlation plot and 2d 
projection. d) Diffusion tensor computed on the trajectories. 
With the information about the first and second momentum of 
the center of mass of the diffusion ellipsoid, it is then possible 
to calculate the following parameter: 
 
The Anisotropy and the Eccentricity are both ratios of the major 
axis of the ellipsoid. The scale for both of them is in the 0 – 1 
range. These two dimensionless parameters represent the 
elongation of the diffusion ellipsoid. In particular, for anisotropy 
a value of 0 would represent a perfect circle (isotropic diffusion) 
and a value of 1 would represent a straight line. 
From the 2DpCF the connectivity map is computed similarly to 
the streamline tracking. The basic principle of streamline 
tracking is to apply an angle of a certain width in the orientation 
of the direction arrow (direction of the major axis of the 
ellipsoid) of a pixel of interest to an adjacent direction arrow. If 
the orientation of the direction arrow is within the angle, the 
113 
 
track is continued. If the orientation of the direction arrow is not 
within the angle, the track ends. The trajectories computed are 
displayed in a 2D connectivity map (Figure 3, c-f). 
 
Figure 3. TOP - HeLa cell expressing GFP, a) Average Intensity, b) 
Anisotropy Map, c) Connectivity map (0.1-1 anisotropy). BOTTOM 
Hela Cell incubated with 0.1 µM of Rhodamine B doped Pluronic 
silica nanoparticles d) Average Intensity, e) Anisotropy Map, f) 
Connectivity map (0.1-1 anisotropy) pCF (5) computed on 8200 
frames 37 ms*frame (λex=900 nm 2-photon laser for GFP and 
λex=514 nm single photon for Nanoparticles). 
 
6.3 DOUBLE STRAND BREAK – DNA DANGEROUS DAMAGE  
Each of the 1013 cells in the human body receives tens of 
thousands of DNA lesions per day. These lesions can block 
genome replication and transcription, and if they are not 
repaired or are repaired incorrectly, they lead to mutations or 
wider-scale genome aberrations. The variety of possible 
damages is quite wide starting from a single base to a big DNA 
fragment denaturation. The repair machinery works in 
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continuous considering the frequency at which DNA damage 
occurs daily.3 
As already mentioned, one of the most dangerous damage is 
the double strands break (DSB), which can be caused by 
irradiation, chemical agents, or ultraviolet light (UV). Double-
strand breaks, in which both strands in the double helix are 
severed, are particularly hazardous to the cell because they 
can lead to genome rearrangements. 
In general, in vitro DNA damage and repair do not occur on a 
naked DNA template but on chromatin where DNA is 
complexed with histones and compacted into higher-order 
structures. The DSB repair mechanism seems to involve 
different chromatin structures where the proteins can 
experience a change in the mobility after the damage. E. Hinde 
et al. revealed the importance of a suitable technique in order 
to discover the time scale of DSB induced effects on the 
mobility of nuclear protein. The technique used by E. Hinde is 
the line pair correlation function useful to investigate with very 
high resolution on the time correlations details the changes of 
the motion of two fluorescent proteins (Ku-EGFP and GFP) by 
analyzing small nuclear regions. The study revealed how 
chromatin undergoes to a rearrangement leading to the 
decrease of organization in the damaged region and to an 
increase in compaction in adjacent regions. All these 
processes together facilitate DNA repair factor recruitment to 
the micro-irradiated region with high spatiotemporal control. 
Indeed, the effects of a DSB can influence the behavior of 
chromatin of the entire nucleus, so 2D-pCF technique is 
proposed here as a promising way to highlight dynamic effect 
on a big cellular sector as the entire nucleus, enabling the 




6.4 DSB REPAIR MECHANISMS 
 
Figure 4. Schematic representation of the two DSB repair 
mechanism, from left A) non-homologous end joining (NHEJ), B) 
homologous recombination (HR), C) single-strand annealing (SSA) 
and D) alternative end-joining (Alt-EJ)5. 
Many mechanisms are today proposed for the repair of double-
strand breaks, the two main ones are: non-homologous end 
joining (NHEJ) and homologous recombination (HR). NHEJ is 
defined as "non-homologous" because the break ends are 
directly ligated without the need of a homologous template, in 
contrast to homology directed repair, which requires a 
homologous sequence to guide repair. NHEJ typically utilizes 
short homologous DNA sequences called microhomologies to 
guide repair. These microhomologies are often presented in 
single-stranded overhangs on the ends of double-strand 
breaks. When the overhangs are perfectly compatible, NHEJ 
usually repairs the break accurately. As showed on the figure 
where the two different processes are represented, KU 
proteins are directly involved on the NHEJ process5,6. These 
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two processes lead to the complete repair of the DSB but can 
lead as well to imperfection and errors. Moreover, the DSB is 
not always completely repaired: the damage can thus activate 
parallel processes promoting different cell pathways as 
apoptosis or cell death. 
   
6.5 HeLa - LASER DAMAGE INDUCE DOUBLE STRANDS 
BREAK 
DSB can be induced on chromatin by different kinds of source 
of energy, such as X-ray exposure or high intensity UV-visible 
light.7 2-photon laser at 780 nm provide, as reported 
previously, a controlled way to obtain a DSB damage, and it 
can operate on a very small nuclear volume avoiding 
membrane and nuclei illness.8 We have performed 2-photon 
laser irradiation using different laser powers in order to have 
the information on the relationship between the delivered 
energy able to generate DSB and the cellular effects. In the 
case of Hela cells expressing Ku-EGFP, a localized laser 
having sufficient power to provoke DSB induces a recruitment 
process for this protein on the damaged region with a very fast 
kinetics.9 The recruitment induces an increase of the protein 
concentration (measured by an increase of the fluorescence 
intensity) on the damaged region. This process is correlated to 
the NHEJ mechanism, describing at molecular level a binding 
of Ku on the broken DNA strand ends. 
On the contrary, upon damaging Hela cells expressing EGFP, 
the recruitment does not occur within the tested laser power 
range and no effect on the fluorescence intensity appears 
(Figure 5). This confirms that laser irradiation modifies the 





Figure 5. Comparison of EGFP and KU-EGFP expressing cell 
damaged with 780 nm two photon laser with different laser 
powers. (scale bar 3 µm) 
The intensity ratio after/before the damage allows to 
investigate the relationship between the amount of energy 
delivered and the protein behavior. In the case of Ku-EGFP, an 
increase of the ratio of fluorescence intensity after/before 
damage, computed on the damaged region, occurs as a 
function of the laser power. This increase of fluorescence 
intensity is related with an energy dose-depending effect that 
can influence the DSB formation and the relative Ku binding. 
For EGFP, which is an inactive protein in the process related 




Figure 6. Fluorescence intensity ratio after/before damage in 
function of laser power of KU-EGFP (black line) and EGFP (red line). 
Immediately after the irradiation, Ku-EGFP is recruited on the 
damaged region. Here Ku-EGFP/DNA complexes evolve over 
time; for this reason the behavior has been monitored up to 240 
min after damage. Ku-EGFP/DNA complexes decrease in size, 
highlighting, probably, the beginning of the DSB repair. 
After 60 min from the irradiation, Ku forms small aggregates on 
domains called foci spread on the entire nucleus.10 
 
Figure 7. Ku-EGFP fluorescence intensity time evolution after 
damage. 
The foci formation is a process that can be regulated by a 
chromatin structural reorganization. To study the evolution of 
the irradiated region and of the foci on the entire nucleus the 
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use of two-dimensional techniques able to discriminate 
dynamic events becomes even more necessary. 
2D-pCF can be computed selecting different pixel distances: 
this parameter allows, on the same data set, to highlight 
processes occurring in different time/space scale. For this 
reason, 2D-pCF is proposed here as the right tool to highlight 
chemical-physic information in two-dimensional fashion of 
complex system: this tool is in fact able to discriminate different 
dynamic processes with the same frames acquisition. 
 
6.6 Ku-EGFP Motion Anisotropy - Damage effect 
2D-pCF analysis led to represent the motion anisotropy map 
and the computation of the average anisotropy value (on the 
entire masked region). Before the damage, the highest 
anisotropy is visible close to the nuclear membrane because 
for Ku this structure is a physical barrier (the protein is 
expressed only inside the nucleus) which block the diffusion 
and influence the possible orientation of the motion. The maps 
acquired for not damaged cells from the beginning to the last 
acquisition (0 to 240 min) reveal the same behavior of 
anisotropy, confirming the orientation of the motion in this 
region before irradiation. When DSB is provoked by the 780 
nm 2-photon laser, on the edges of the damaged area Ku 
recruitment set off an increase of anisotropy indicating the 
formation of an obstacle which can be due to the complex of 
the damaged DNA and this protein. At the same time, close to 
the membrane, the motion become structureless probably 
because of the recruitment activation (decrease of the 
anisotropy close to the membrane). The formation of the foci 
occurs and the recruitment size decreases on irradiated area, 
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changing drastically the anisotropy computed by 2DpCF 
(Figure 8).  
 
Figure 8. Fluorescence intensity and anisotropy map for damaged 
cell and control cell (top and bottom, respectively). 
The computation of the averaged anisotropy value measured 
on the collected pixels allows to have a statistical information 
about the effect of the DSB correlated proteins response of the 
entire nucleus. The localized irradiation causes an averaged 
increase of the motion anisotropy which is due to the activation 
of Ku proteins. The effect of damage is confirmed analyzing the 
anisotropy of the not damaged cells, which is constant, 
indicating that the changes of motion are due to DSB (Figure 
9). In general, for the motion of protein in complex 
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environments, an anisotropy increase can be described as an 
increase of motion compartmentalization.  
 
 
Figure 9. Top, Anisotropy trends of not damaged cells (black line) 
and 90 mW damaged HeLa Ku-EGFP expressing cells (red line) 
over time. Bottom: variation of motion anisotropy (Δ Anisotropy=1h 




The effect of the damage and the activation of the repair 
processes on the chromatin can be described by the 
trajectories obtained computing the connectivity map. This tool 
provides a very detailed map of the connections and the 
barriers in the system. To rationalize the trajectories can be 
useful to focus the description about region of interest as the 
damaged sector, the nuclear membrane and the foci. The 
connectivity map (Figure 10) at correlation distance of 5 pixels, 
describes a short-range mobility in a fast time scale. In these 
conditions connectivity maps reveals the changes of Ku motion 
close to the membrane provoked by the irradiation. The motion, 
close to nuclear barrier is composed by trajectories tangential 
to the membrane, where statistically Ku motion becomes more 
discontinued once chromatin is damaged. Close to DSB region 
and to Foci the trajectories highlight the process of Ku 
recruitment. The connectivity map of EGFP doesn’t show any 
significant evidence of changes on the trajectories. This fact 
confirms that there are not observable effects of damage on 




Figure 10. From top to bottom: fluorescence intensity map of Ku-
GFP expressing HeLA cell before immediately, 60 and 240 minutes 
after the damage. Relative connectivity map computed at 5 pixels of 
correlation distance. Membrane is highlighted in green, damaged in 
red and foci in blue. 
 
Changing the correlation distance, it is possible to control the 
spatiotemporal scale of the correlation which can be useful to 
highlight different processes. For this reason, here is reported 
a comparison between the output of different correlation 
distance: at 5 (700 nm) and at 10 pixels (1400 nm). Focusing 
on the damaged region, the anisotropy map shows two 
different patterns of obstacles which involved directly Ku 
proteins. The different pattern between 5 and 10 pixels is 
confirmed by the connectivity map where different trajectories 
are highlighted. In this region two different time scale 
processes are proposed, i.e.: pCF (5) short and fast 
recruitment and pCF (10) slower Ku reorganization probably 
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combined with big chromatin displacement. These results can 
provide a good example suggesting the importance of the 
development new two-dimensional techniques with a high 
spatiotemporal control where the traditional line correlation 
cannot allow description of a whole cellular sectors (Figure 11).  
 
Figure 11. form the top to the bottom: Intensity map of KUEGFP 
expressing cell damaged with 90 mW at 780 nm. Anisotropy map 
computed at correlation distance 5 and 10 pixels. Connectivity map 
computed at 5 and 10 pixels and zoom close to damaged region.  
6.7 Inhibition of DNA Damage Response  
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In order to maintain genomic stability, cells have developed 
sophisticated signaling pathways to enable DNA damage or DNA 
replication stress to be resolved. As key mediators which are 
involved in this DNA damage response (DDR), different proteins can 
be considered: the ATM and ATR kinases, PARP and DNA-PK, 
which are able to induce cell cycle arrest and to facilitate DNA repair 
via their downstream targets. Inhibiting the DDR has become an 
attractive therapeutic concept in cancer therapy, since (i) resistance 
to genotoxic therapies has been associated with increased DDR 
signaling, and (ii) many cancers have defects in certain components 
of the DDR rendering them highly dependent on the remaining DDR 
pathways for survival.13 The knowledge on the repair mechanism 
and the related chemical physical behavior of the chromatin could 
open the possibility to formulate new therapeutic tools able to control 
the DDR. For this reason, to understand the interconnection 
between different cell repair processes that can influence the 
dynamic of chromatin, three kinds of inhibition have been selected. 
 
6.7.1 PARP 
Poly(ADP-ribose) polymerase (PARP)  is a family 
of proteins involved in a number of processes such as , genomic 
stability, and 14. PARP can be activated in cells experiencing stress 
and/or DNA damage. Activated PARP can deplete the ATP of a cell 
trying to repair the damaged DNA. ATP depletion in a cell can lead 
to lysis and cell death (necrosis). The PARP inhibition (PARPi, final 
i is for inhibitor) should works primarily by blocking PARP enzyme 
activity, thus preventing the repair of DNA damage and ultimately 







DNA Protein Dependent Kinase (DNA-PK) is an enzyme that is 
involved in NHEJ, which rejoins double-strand breaks. 
Autophosphorylation of DNA-PKs appears to play a key role in 
NHEJ and is thought to induce a conformational change that allows 
end processing enzymes to access the ends of the double-strand 
break. DNA-PK also cooperates with ATR and ATM (A-T, ataxia–
telangiectasia; ATM, ataxia–telangiectasia mutated; ATR, ataxia–
telangiectasia and Rad3 related) to phosphorylate proteins involved 
in the DNA damage checkpoint. For this reason, the other two kinds 
of inhibition tested are DNA-PKi and ATMi and DNA-
PKi+ATMi+ATRi 18.  
 
6.7.3 ATM and ATR 
ATM and ATR are members of the phosphatidylinositol 3-
kinaserelated kinase (PIKK) family of serine/threonine protein 
kinases. The cellular functions of these protein kinases range from 
regulation of the DNA damage response (DDR) to cell survival, 
proliferation, metabolism, differentiation, motility and nonsense-
mediated mRNA decay19. 
 
6.8 Inhibition effect on the KU-EGFP motion 
The biological effects of these kinds of inhibition are today still under 
investigation. There are many examples of cellular DDR behaviors 
where active proteins are inhibited20. Here is proposed 2D pCF, as 
a powerful tool able to disclose the effect of inhibition of DDR on Ku-
EGFP mobility. This investigation indicates some chromatin 
structural changes when some processes are repressed before and 
after the irradiation. The motion anisotropy computed at 5 pixels of 
correlation distance (Figure 12) indicates which are the effects of 
these inhibitors on Ku mobility before and after the damage. Higher 
average value of anisotropy can represent different kinds of diffusion 
related to an increase of compartmentalization of chromatin. 
Probably, repressing certain processes, the cells are stimulated to 
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overcome the inhibitions, and this can alter the mobility of Ku-EGFP 
proteins also before the DSB formation.  
 
Figure 12. Trends of the Motion Anisotropy for: Control (red line), 
PARPi (blue line), DNA-PKi+ATMi (dark green line) and DNA-
PKi+ATMi+ATRi (purple line) inhibitors. DSB induced with 90 mW 
at 780 nm.  
The inhibitors tested can influence other processes not only related 
with DDR. Probably the increase of anisotropy of DNA-
PKi+ATMi+ATRi provoked by the damage and the relative high 
anisotropy after one hour can be correlated to process of Ku/foci 
formation. Indeed, counting the number of foci formed after one hour 
from the damage, the highest number of foci is revealed under the 
effect of this inhibitor, (Figure 13, A). 
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Figure 26. A) Box plot of number of foci expressed after one hour 
from damage with laser power of 90 mW at 780 nm for: control as 
no inhibited (red box), PARPi (green box), DNA-PKi+ATMi (Blue 
box) and DNA-PKi+ATMi+ATRi (cyan box). B) KU-EGFP expressing 
cell where FOCI are marked in blue.  
To explain a possible reason about the relationships between the 
highest number of foci and the average increase of anisotropy, it is 
useful to understand how the foci are structured. In order to 
understand the structure of foci a colocalization of two different 
labels has been carried out staining with Ku red antibody and green 
antibody for Telomeric repeat-binding factor 2 (a protein which 
protect and regulate the telomeres length). 
Firstly, for Ku red, the foci are highlighted as well as the Ku-EGFP 
expressing cells, demonstrating the natural formation of these 
aggregates after irradiation. We co-stained cells Ku and telomer 
factor are colocalized in the foci as well as in the damaged region 
(Figure 14). This could mean that the Ku recruitment process related 
to the DDR involves chromatin components as the telomers which 
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can change chromatin structure altering the mobility of certain 
proteins inside the nucleus.  
 
Figure 27. Hela cell fixed and co-stained with A) KU red antibody 
marker, B) TRF" green antibody marker C) merged images 
 
6.9 CONCLUSION 
Here I reported the application of a novel fluorescence two-
dimensional correlation technique for the investigation on the 
dynamic repair process of double strand break of DNA. These 
processes are induced by the irradiation with high power two-photon 
laser at 780 nm in a small region of the cellular nucleus. 
In particular, the technique provided, with very high spatiotemporal 
resolution, the information on motion anisotropy of EGFP and Ku-
EGFP, a DSB repair active fluorescent labeled protein. The final 
outputs of 2D-pCF are anisotropy and connectivity map. Anisotropy 
map shows how is structured the motion and the connectivity 
highlights the pattern of trajectories before and after the irradiation 
yielding which is the behavior of physical chemical properties of Ku 
when DSB occurs.  
The application of 2D-PCF to DDR response allowed calculating the 
effect of the damage on local recruitment processes involving Ku. 
Indeed, when HeLa cells are damaged two different processes for 
Ku are observed: the recruitment on the damaged region with very 
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fast kinetics (few seconds after irradiation) and, on longer time scale, 
the recruitment on structure called foci (slow kinetics 30 minutes).  
These biological processes are related to DDR and can be 
investigated looking how this protein moves inside the nucleus. The 
DSB damage can remodel the chromatin changing the mobility of 
Ku provoking an increase of the anisotropy. This can be described 
as an increase of the compartmentalization for Ku which can find 
more obstacles during its activity while for EGFP, an inactive protein, 
anisotropy is constant.  
Moreover, I have investigated the effects on the motion of Ku 
provoked by three different DDR inhibitors that influence how this 
protein can move inside the nucleus. The inhibition of DDR 
processes can influence the Ku mobility as well as the number of 
foci formed. In particular DNA-PKi+ATMi+ATRi inhibition induces 
the formation of the highest number of foci and the biggest increase 
of anisotropy which can be described by colocalization of Ku and 
telomers binding factor which is one of the responsible of protecting 
and regulating the telomer length. 
Concluding, I believe that 2D-pCF is a powerful method which can 
provide the access to physical chemical information, in a two-
dimensional form, of dynamic processes of nanostructured 
fluorescent materials (ranging from protein to nanoparticles), useful 
to improve the knowledge on biological processes and, in the future, 
for the development of theranostic nanomaterials. 
 
 
6. 10 Technical Notes 
 
Laser Damage 
In this investigation the damage has been achieved by 
irradiating at 780 nm with 2-photon laser. This treatment has 
been carried out inducing with a linear scansion, in a small 
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region of interest (0.3 by 3 µm, a scan speed of 16 µs/pixel) 
with different laser powers (0, 40 and 90 mW). 
 
Laser scanning Acquisition Method for 2D pCF(δr) 
2D-pCF analysis, similarly as the other correlation techniques 
needs a discrete number of events (fluctuations) to have 
reliable statistics able to gain correlation functions with a good 
resolution.  
The acquisition in terms of pixel dwell time is another crucial 
parameter which, as reported previously, control the time scale 
of the correlation11,12 To get the best compromise of the frame 
acquisition and scan speed aiming the time resolution of the 
processes involved, the data suitable for 2D-pCF are acquired 
using a confocal Microscope Zeiss LSM 880 recording 8200 
frames with very fast laser scansion (37 ms per frame a pixel 
size of 140 nm and a frame of 128 by 128 pixels). To avoid side 
effects during the scansion due to the long exposition of the 
cell to the laser for the scansion a very delicate two-photon 
excitation at 900 nm (about 0.8 mW) is used to acquire the 
frames selecting the lowest laser power to avoid 
photobleaching (which can alter the correlation as well).  
 
Laser damage and the frame acquisition for the 2D-pCF 
analysis have been carried out using water immersion 
apochromat 40x objective with NA 1.2  
 
2D-pCF pixel distance and analysis 
The pixel distance for the correlation is a key parameter, since 
at different distance, the analysis can highlight phenomena 
which occurs in different spatiotemporal scales. 
Experimentally, the pixels distances choice to compute the pair 
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correlation function in this work are 5 and 10 pixels (PSF about 
3 pixels). In order to get statistical information pCF analysis is 
carried out on the nucleus on a set of three cells at list, 




Each inhibitor is dissolved in DMSO. The cells are incubated with 
the inhibitor solution in DMEM for one hour and before the imaging 
the medium is changed. Below the percentages are in v/v. For each 
cell treatment, the inhibitor stock is mixed in the cellular medium as 
follow:  
Control -> 0.24% DMSO  
PARPi -> 0.1% PARPi +0.14% DMSO 
DNA-PKi + ATMi -> 0.1% ATMi + 0.1%DNA-PKi +0.04 DMSO 




HeLa cells are damaged in the same way described before. The 
cells are co-stained after PFA fixation (carried out one hour after 
damaging) with red marker antibody for KU and a green marker 
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Theranostic nanomaterials and genome interpretation are expected 
to provide solutions for unsolved medical problems allowing better 
life conditions and improving life expectation of patients. 
Nevertheless, since biological environments are very complex and 
nanoparticles, interacting with macro-molecules, form self-
assembled structures referred as biomolecular corona, it is very 
important to consider that they will present different 
chemical/physical properties, biological activity and biodistribution in 
these conditions.  It is therefore evident that to understand and 
control these interactions is of great importance for the application 
of new nanomaterials in medicine. 
The results obtained in this PhD thesis provide precious information 
on the design and preparation of nanomaterials for theranostic 
applications based on dye doped Pluronic F-127 Silica 
Nanoparticles and for the development of fluorescence-based 
methods or technical tools for an improved characterization of such 
materials especially in a biological environment. 
In particular, I have investigated a new method based on fluorescent 
solvatochromic dyes (Prodan and Nile Red), that can be 
conveniently used to map the polarity of neighboring 
nanoenviroments (chapter 3) in order to understand the composition 
of complex nanoarchitecture, as PluSNPs. For these nanoparticles 
we were able to evidence the complex architecture of the Pluronic 
shell, its multi-polarity gradient from the inner, more lipophilic part, 
to the more hydrophilic outer one, ruling the host/guest abilities of 
these structures. These results obtained for a particular 
nanostructure, are extremely interesting; but it is important to 
underline that the method can be of general application, being 
suitable for the mapping of nano-polarities in many nanostructured 
materials and, in general, in soft interfaces.  
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I have then taken advantage from the information gained with the 
solvatochromic method to design PluSNPs for drug delivery 
purposes and, with suitable changes in the synthetic strategy, I have 
been able to incorporate in a single nanostructure, an average of 70-
100 units of Sorafenib Tosylate, a very common chemotherapeutic 
lipophilic drug (chapter 2). This drug is widely used in clinical 
practice for the treatment of renal and liver carcinoma. We 
monitored in controlled conditions in vitro, the release kinetic of this 
drug from the particles occurring in more than two days, an already 
very good result that can be still tuned and optimized in the next 
future. Moreover, the same drug delivery nanoplatform has revealed 
very promising anti-angiogenic properties in several in vitro 
dedicated cellular tests.  
As already mentioned, we were well aware that to tune these 
properties it is fundamental a deep understanding of the formation 
of the biomolecular corona. To this goal we have investigated a kind 
of model system following the interactions among PluSNPs and two 
dye labeled hyaluronic acids with different molecular weights 
(chapter 5). Interestingly, we were able to monitor the 
conformational reorganization of the hyaluronic acid by observing 
the changes on the optical properties of the Rhodamine B 
chemically anchored to the hyaluronic acid chains induced by these 
interactions. Further evidences and a deeper understanding have 
been possible by following the energy transfer process among 
Rhodamine B and suitable fluorophores embedded in the core of ad 
hoc designed nanoparticle. We have followed the hyaluronic 
acid/PluSNPs nanoparticles ensemble with two different correlation 
techniques (DLS and FCS). Moreover. we monitored the biological 
effect of these self-assembled nanoarchitectures observing their 
uptake in a tumor cell line in vitro. Interestingly, the interaction with 
the Hyaluronic acid makes the internalization of PluSNPs faster, a 
result that, if confirmed also in vivo could be of significant importance 
for the optimization of the drug delivery process. 
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In the last part of my research work I have tested and optimized the 
application of a novel fluorescence cross correlation technique 
developed at Laboratory of Fluorescence Dynamics of University of 
California, namely 2D-pCF. As also shown by this work, this 
technique is able to provide the maps of dynamical processes 
yielding statistically the motion anisotropy and trajectories of 
fluorescent objects inside cells with very high spatiotemporal 
resolution. 2D-pCF can be useful for the description of different 
phenomena related to nanoparticle intracellular localization. With 
the aim to follow a step by step approach, as a first model I focused 
the investigation on chromatin reorganization monitoring the 
dynamical processes of a protein involved in the repair mechanism 
of DNA double strands breaks. I evidenced that when DNA is 
damaged, the chromatin undergoes a reorganization that changes 
the motion of the proteins responsible for the protection of DNA and 
in general of nucleic materials. Although only few preliminary tests 
have been carried out on PluSNPs, this technique can be easily 
extended also to most fluorescent nanoarchitectures, representing 
a powerful tool to follow different processes inside cell. 
 
I believe this work can provide interesting stimuli for the scientific 
community as starting point for the development of nanostructured 
materials, self-assembled biomolecular corona and fluorescence-
based techniques for the design and investigation in the field of 





PRYNCIPLES OF PHOTOPHYSICS 
 
A.1 ELECTRONIC EXITED STATE, JABLOSNKY DIAGRAM  
To introduce the applications which takes advantage of fluorescence 
processes is useful to shows the origin and the behavior of an 
electronic exited state. Electromagnetic radiation and matter can 
interact in different ways. Photochemistry is interested in the 
conversion of the energy (hν) of a photon absorbed by a chemical 
species in electronic energy, causing the transfer of an electron 
toward an orbital possessing higher energy. The species turns from 
its electronic ground state A to an electronic excited state A*, which 
possesses a different electronic configuration:  
𝐴 + ℎ𝜈 → 𝐴∗ 
This different electronic distribution causes the excited states of a 
chemical species to have physicochemical properties so different 
from those of the ground state that they can be considered different 
chemical species. For this reason, it is possible to define 
photochemistry as the chemistry of excited states. A photon can be 
absorbed and provoke the formation of an electronic excited state 
only if its energy hν exactly corresponds to the energy difference 
between the excited and the ground state.   Absorption electronic 
transitions occur in a time scale of the order of femtoseconds (10-15 
s, Franck Condon Principle), creating excited states which are 
transient and can deactivate in different ways, shown in the 
Jablonski diagram (Figure 3). In this diagram electronic states (the 
singlets S0, S1 and the triplets T1 and T2) are represented by thicker 
lines. The distinction between states with different spin multiplicity is 
due to the fact that transitions between these states are partially not 
allowed. Thinner lines represent the vibrational levels of the 
electronic states.   After the energy absorption and reaching an 
excited vibrational level of an S2 electronic excited state, the 
molecule goes rapidly (< 10-12 s) to the ground vibrational level of 
that excited state (vibrational relaxation); then internal conversion 
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occurs, passing from the ground vibrational level of S2 to the 
isoenergetic vibrational level of S1, the electronic state at lower 
energy (< 10-12 s). Another vibrational relaxation is then observed 
toward the ground vibrational state of S1, and at this stage the 
excited molecule can deactivate in two ways:  
1- Non-radiative deactivation: the energy is released as 
vibrational energy generating heat. If this process occurs 
between two states with the same spin multiplicity we speak 
about internal conversion (10-12-10-6 s), while if the states 
have different spin multiplicity we have intersystem crossing 
(10-11 -10-6 s). The successive vibrational relaxation leads in 
the first case to the ground vibrational level of S0, in the 
second case to that of T1;  
2- Radiative deactivation: it is a process that generates 
luminescence and it is defined fluorescence if it occurs 
between states with the same spin multiplicity, 
phosphorescence if it occurs between states with different 
spin multiplicity. Similarly to S1, T1 can deactivate to S0 by 
radiative deactivation (phosphorescence, 10-4-102 s) or by 
nonradiative deactivation (intersystem crossing, 10-3-10 s, 
and successive vibrational relaxation to S0). Long-lived 
states such as T1 can undergo photochemical reactions, for 
example with oxygen, producing other chemical species. 
Generally speaking, since the time scale to decay to S1 and 
T1 are shorter than that necessary to pass from S1 and T1 to 
S0, only lowest energetic states of each spin multiplicity (that 
is S1 and T1) live enough to undergo luminescence (Kasha’s 




Figure 28. Jablonsky diagram for a generic molecule: 




Many relevant chemical and physical phenomena such as 
thermodynamics and reaction kinetics, as well as the position and 
intensity of the electronic absorption and emission bands, are often 
strongly dependent on the solvent. The basis of these effects on 
chemical equilibria and spectroscopic properties is the solvation of 
reagents and products. The solvation depends on the intermolecular 
forces between solute and surrounding solvent molecules, which 
include non-specific forces, such as electrostatic and polarization 
forces, and specific forces such as hydrogen bonds. The influence 
of solvents on the chemical equilibrium position was discovered in 
1896 by Claisen and Wislicenus independently of each other. These 
results were examined by Stobbe, who in 1903 divided the solvents 
into two groups, based on their ability to isomerize some tautomeric 
compounds, with subsequent subdivision in solvent donors of 
hydrogen bonds (HBD, protic solvents) and non-hydrogen bond 
donors (non-HBD, aprotic solvents).  Hantzschlater instead 
observed the displacement of the absorption and emission maxima 
at longer or shorter wavelengths of some molecules (fluorophores) 





Figure 29. Schematization of Jablonsky diagram for a positive 
solvatochromic dye 
This phenomenon has taken the name of solvatochromism. The 
solvatochromism manifests itself in molecules having a different 
dipole moment for the ground state and the excited state. Solvents 
can therefore stabilize the two electronic states in a different 
proportion, thus varying the energy gap between them and therefore 
the energy of the transition. In general, the transitions between two 
states, both in absorption and in emission, take place in a very short 
time, much lower than that of the motion of the nuclei, therefore 
considered to be stationary. Therefore, there is no reorganization of 
the solvent molecules causing the scheme of solvation of the excited 
state and that of the ground state to remain unchanged (Frank-
Condon principle). However, if the residence time in an excited state 
is large enough, a reorientation of the solvent molecules can occur, 
with associated internal conversion, which brings the molecule into 
a lower energy vibro-electronic state and, from this new energy 
level, it can take place a radiative relaxation with fluorescence 
emission that brings the molecule to the ground state2. In this case, 
the energy emitted by the solvatochromic dye molecule will be as 
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low as the stabilization effect of the excited state operated by the 
solvent is greatest. There are two types of solvatochromism, 
negative and positive. If, as the solvent polarity increases, the 
fundamental state of the molecule is more stabilized than its first 
excited state, we observe hypsochromic shift (towards high energies 
in the spectrum) and the solvatochromism is called negative. Vice 
versa, if as the solvent polarity increases the excited state is 
stabilized more than the fundamental one, the solvatochromism is 
called positive and we observe a batochromic shift (towards low 
energies). The solvatochromic probes are widely used for the study 
of polarity in complex systems or in the diagnostic field as 
bioluminescent sensors in imaging techniques 3,4.  
 
A.3 Electronic Excitation Energy Transfer  
With the term electronic excitation energy transfer we indicate the 
process in which an excited molecule of a donor D* decays to its 
ground state D with the simultaneous transfer of its excitation energy 
to a molecule of acceptor A, which is thus led to an excited state A*:  
𝐷∗ + 𝐴 → 𝐷 + 𝐴∗ 
it is possible to observe this phenomenon exciting D in a spectral 
region in which it absorbs but A does not: if energy transfer occurs, 
D* emission is quenched and at the same time the appearance of 
the emission of A* is observed, which is called sensitized emission. 
In the case in which D and A are different molecules of the same 
chemical species we speak about homo energy transfer. It is 
possible to observe also intramolecular energy transfer in the case 
of a (super)molecule containing a donor and an acceptor, separated 
by a spacer L:  
𝐷∗ − 𝐿 − 𝐴 →  𝐷 − 𝐿 − 𝐴∗ 
Two possible mechanisms of energy transfer exist, radiative one 
and non-radiative one.  The radiative mechanism (also called trivial 
energy transfer) does not require the direct interaction of D and A, 
but it occurs via the electromagnetic field produced form the photons 
emitted by D, which can be absorbed by A, provided that an overlap 
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between the emission spectrum of D and the absorption one of A 
exists.  This mechanism consists of two different steps:  
𝐷∗ →  𝐷 + ℎ𝜈′  (Emission of the Donor) 
𝐴 + ℎ𝜈′ →  𝐴∗  (Absorption of the Acceptor) 
It is possible to correlate the probability of absorption of A of a 
photon emitted by D*, that is the probability of energy transfer 
(aD*→A), with the overlap between the emission spectrum of D and 
the absorption one of A. In particular a relation stands between aD*→A 
and the overlap integral 𝐽, defined as    





where 𝐹𝐷 is the normalized emission spectrum of D (the area under 
the spectrum is equal to 1) and  𝐴(𝜆)     is the absorption spectrum 
of A in dm3·mol-1·cm-1. So as  𝐽 increases, the probability of radiative 
energy transfer linearly increases. This probability is also directly 
proportional to the concentration of A, to the optical path length and 
inversely proportional to the luminescence quantum yield of D. The 
radiative energy transfer can occur over extremely long distances: 
solar irradiation on Earth is a striking example. It is necessary that 
the transition of absorption in the acceptor is spin-allowed so that 
the radiative energy transfer can occur: thus singlet(D*)-singlet(A*) 
and triplet(D*)-singlet(A*) transfers are allowed, while singlet(D*)-
triplet(A*) and triplet(D*)-triplet (A*) transfers are not allowed.  
The non-radiative mechanism, on the other hand, requires an 
intermolecular interaction between D and A mediated by the 
electromagnetic field. The energy transfer between the partners 
occurs in resonance conditions, involving isoenergetic non-radiative 
transitions between D* and A. Also, in this case the probability of 
energy transfer is directly proportional to 𝐽. The theoretical 
description of the process leads to obtain that the interaction 
between D* and A consists of a Coulombic term (Förster 





Figure 30. energy transfer via Coulombic mechanism (left) and with 
exchange mechanism (right) 
The Coulombic mechanism arises from the coupling of the electronic 
transition moments of electric dipole of the transitions D*->D and A-
>A*. This interaction is governed by Förster’s equation, which 








 Where 𝜏𝐷   is the lifetime of the donor in the absence of the acceptor 
and 𝑅0   is the Förster distance, that is the distance between D and 
\A at which the energy transfer rate ( 𝑘𝐸𝑇  ) is equal to the decay rate 
of the donor in the absence of the acceptor ( 𝑘𝐸𝑇 =
1
𝜏𝐷
 ). At this 
distance half of the molecules of D decay via energy transfer. Förster 
distance is correlated to the overlap between the emission spectrum 
of D and the absorption spectrum of A by means of the following 
relation:  
𝑅0




Where χ is the orientational factor which describes the relative 
orientation of the electric dipole moment of D and A (it is assumed 
to be equal to 2/3 in the case of freely rotating D and A),  𝛷𝐷  is the 
fluorescence quantum yield of D in the absence of A,  𝑛 is the 
refractive index of the solvent, 𝑁𝐴 is the Avogadro’s constant, is the 
luminescence spectrum of D normalized to 1m and  𝐽 is the spectral 
overlap. The higher the overlap between the emission spectrum of 
A and the absorption spectrum of A, the higher the value of  𝑅0. 
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Typical values are about 20-100 Å. It is possible to define an 





which is linked to  𝑅𝐷𝐴







 which highlights that the efficiency of the energy transfer process is 
equal to 0.5 when  𝑅𝐷𝐴 = 𝑅0. It is possible to experimentally obtain 
𝜂  from the fluorescence quantum yield of D in the presence of A ( 
𝛷𝐷𝐴) and in its absence (𝛷𝐷), or from lifetimes in the two conditions 
(𝜏𝐷𝐴  , 𝜏𝐷):  








The processes of Förster type energy transfer are generally allowed 
if the transition in D and in A does not involve spin changes of the 
single species. On the contrary Dexter type energy transfer 
dominates. The exchange interaction requires a simultaneous 
double electronic exchange involving the LUMO of D and the HOMO 
of A (Figure 3) and it is a short-range interaction, becoming 
important when 𝑅𝐷𝐴  is ≤ 5 Å. According to Dexter model, the kinetic 
constant for the exchange mechanism decays exponentially with   








 where 𝐾  is a factor related to the specific orbitalic interaction, 𝐽𝑒𝑥 is 
the normalized overlap integral and 𝐿 is an average Van der Waals 
radius which simulates molecular dimensions5.   
 
A4 Electronic absorption spectra  
 For the acquisition of electronic absorption spectra, a double beam 
spectrophotometer UV/Vis Perkin Elmer Lambda-45 was used. The 
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amount of light absorbed is provided by the ratio of the intensity of 
incident light (𝐼0) and the intensity of transmitted light (𝐼𝑡) and is 





A is related to the chromophore concentration by the Lambert Beer 
equation as following:  
𝐴 = 𝑐 𝑙 
Where 𝑐 is the chromophore concentration express in mol/L,  is the 
molar extinction coefficient (mol/L)-1cm-1 and 𝑙 is the optical path of 
the sample (1 cm optical path of the cuvette).  
  
A5 Emission and excitation spectra  
 The registration of the emission and excitation spectra was 
performer using a spectrofluorimeter Perkin Elmer LS55 and a 
spectrofluorimeter Edinburgh FLS920. 
A very used quantity in photophysics is the luminescence quantum 
yield (𝛷𝑃𝐿, QY), defined as the ration between the number of emitted 
photons and the number of photons absorbed by a species in the 
same time and for a determined excitation wavelength: 
𝛷𝑃𝐿 =
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑒𝑚𝑖𝑡𝑡𝑒𝑑 𝑝ℎ𝑜𝑡𝑜𝑛𝑠
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑎𝑏𝑠𝑜𝑟𝑏𝑒𝑑 𝑝ℎ𝑜𝑡𝑜𝑛𝑠
 
For the assessment of luminescence quantum yield with a relative 
method we need a reference which its quantum yield is known. The 
species used as a reference has to emit in the same spectral region 
in which the sample emits so that emission spectra are obtained in 
the same experimental conditions. For the assessment of 𝛷𝑃𝐿 we 
adopted the following experimental procedure: the absorption 
spectra of the sample and of the reference were registered and, 
when possible, isoabsorption points were used as excitation 
wavelength for the registration of emission spectra. The following 
















Where 𝛷𝑟𝑒𝑓 is the referment fluorescence QY.  𝐼𝑟𝑒𝑓, 𝐴𝑟𝑒𝑓  and 
𝜂𝑟𝑒𝑓are the referment emission intensity, the absorption at excitation 
wavelength and the dielectric constant of the solvent respectively. 
𝐼𝑥, 𝐴𝑥 and 𝜂𝑥 are the analogous parameters for the sample. 
 
A6 Excited state lifetime measurements  
 Excited state lifetime measurements were performed using a 
spectrofluorimeter Edinburgh Analytical Instruments FLS920, 
equipped with a time-correlated single-photon counting device, 
which is able to measure lifetimes in a range between 0.5 ns and 30 
µs. The time-correlated single-photon counting is based on the 
probability that a single photon emitted by a luminescent sample is 
collected by a proper high sensitivity detector: this probability is 
statistically correlated with the variation of the concentration of the 
excited states in solution. 
 
A.7 Dynamic Light Scattering 
Dynamic Light Scattering (DLS) measurements were performed 
using a Malvern Instruments DLS ZetaSizer Nano-ZS (Figure 2.7). 
With this instrument it is possible to determine the dimension of 
particles having a diameter between 1 nm and 10 μm. The DLS 
technique allows the measurements of submicrometric particles. It 
exploits the study of Brownian motions to determine the 
hydrodynamic diameter of particles suspended in solution. The 
hydrodynamic diameter is obtained by the correlation of the 
scattering intensity fluctuations recorded over time experimentally 
irradiating the sample with a 633 nm laser. The laser produce scatter 
events when particles diffuse through the laser beam, so recording 
and correlating over time the fluctuations is possible to get the 
particle size distribution. The particle size distribution is obtained 
from the relative scattering intensity graph of the several particle size 
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classes (intensity size distribution). It is also possible to obtain this 
distribution as a function of particle volume, or particle number. Let 
us consider, for example, a sample containing two populations of 
spherical particles having a diameter of 5 and 50 nm respectively 
and present in the same number (Figure 4). As far as the number of 
particle is concerned, the graph consists of two peaks, one at 5 nm 
and the other at 50 nm, with a 1:1 ratio. If we convert the number 
distribution in volume distribution, the two peaks ratio is 1:1000, 








. If we switch to 
intensity distribution, the ratio becomes equal to 1:106 according to 
Rayleigh approximation. 
 
Figure 31. number, volume and intensity distribution of a sample 
containing spherical particles of 5 and 50 nm diameter in equal 
numbers.  
A.8 Fluorescence Correlation Spectroscopy 
Fluorescence Correlation Spectroscopy is a technique where the 
fluorescence intensity fluctuations are correlated over time in order 
to describe the dynamic of the system. FCS can provide information 
as diffusion coefficient of the fluorophore and concentration with 
very high sensitivity because it observes a small number of 
molecules (nanomolar to picomolar concentrations) in a small 
volume (~1μm3)6. Commonly, FCS is employed in the context of 
optical microscopy, in particular Confocal microscopy or two-photon 
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excitation microscopy. In these techniques light is focused on a 
sample and the measured fluorescence intensity fluctuations (due 
to diffusion, physical or chemical reactions, aggregation, etc.) are 
analyzed using the temporal autocorrelation. The classical FCS 
setup  (Figure 5)consists of a laser line (wavelengths ranging 
typically from 405–633 nm (cw), and from 690–1100 nm (pulsed)), 
which is reflected into a microscope objective by a dichroic mirror. 
The laser beam is focused in the sample, which contains fluorescent 
particles (molecules) in such high dilution, that only a few are within 
the focal spot (usually 1–100 molecules in one fL). When the 
particles cross the focal volume, they fluoresce. This light is 
collected by the same objective and, because it is red-shifted with 
respect to the excitation light it passes the dichroic mirror reaching 
a detector, typically a photomultiplier tube. The FCS curve by itself 
only represents a time-spectrum. Conclusions on physical 
phenomena have to be extracted from there with appropriate 
models. The parameters of interest are found after fitting the 
autocorrelation curve to modeled functional forms7. The correlation 






The time-dependent fluorescence intensity (I(t)) is then analyzed in 
terms of its temporal autocorrelation function (G (τ)), which 
compares the fluorescence intensity at time t with the intensity at (t 
+ τ), where τ is a variable interval, averaged over all data points in 




Figure 32. FCS setup and analysis representation 
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